FZMD / Fuse Medical, Inc. - Pengajuan SECLaporan Tahunan, Pernyataan Proksi

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number 000-10093 Fuse Medical, Inc. (Exact name of issuer as specified in its chart

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 27, 2023 FUSE MEDICAL, INC. (Exact name of Registrant as Specified in Its Charter) Delaware 000-10093 59-1224913 (State or Other Jurisdiction of Incorporation) (Commission F

Fuse Medical Inc. Announces Decision to Voluntarily Terminate Registration of Its Common Stock with the SEC.

Exhibit 99.1 FOR IMMEDIATE RELEASE Fuse Medical Inc. Announces Decision to Voluntarily Terminate Registration of Its Common Stock with the SEC. Richardson, Texas, September 27, 2023 – Fuse Medical Inc. (OTCPINK: FZMD) (“Fuse” or the “Company”) Fuse Medical Inc., an emerging manufacturer and distributor of innovative medical devices for the orthopedic and spine marketplace, has announced that it ha

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 15, 2023 (August 14, 2023)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 15, 2023 (August 14, 2023) FUSE MEDICAL, INC. (Exact name of Registrant as Specified in Its Charter) Delaware 000-10093 59-1224913 (State or Other Jurisdiction of Incorporation

FUSE MEDICAL, INC. ANNOUNCES SECOND QUARTER 2023 FINANCIAL RESULTS

Exhibit 99.1 FOR IMMEDIATE RELEASE Contact: Fuse Medical, Inc. Attention: Lawrence Yellin, CFO 1565 North Central Expressway, Suite 220 Richardson, Texas 75080 Office (469) 862-3030 Facsimile (469) 862-3035 [email protected] FUSE MEDICAL, INC. ANNOUNCES SECOND QUARTER 2023 FINANCIAL RESULTS August 15, 2023 RICHARDSON, TX, [DATE] /Businesswire/ -On August 14, 2023, Fuse Medical, Inc. (OTCPINK: F

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: June 30, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 000-10093 Fuse Medical, Inc. (Exact name of regis

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 26, 2023 (June 23, 2023) FUS

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 26, 2023 (June 23, 2023) FUSE MEDICAL, INC. (Exact name of Registrant as Specified in Its Charter) Delaware 000-10093 59-1224913 (State or Other Jurisdiction of Incorporation) (C

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: March 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 000-10093 Fuse Medical, Inc. (Exact name of registrant as specifie

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(A) OF THE SECURITIES EXCHANGE ACT OF 1934

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(A) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Defi

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(A) OF THE SECURITIES EXCHANGE ACT OF 1934

DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(A) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Pro

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 18, 2023 (April 14, 2023) FUSE MEDICAL, INC. (Exact name of Registrant as Specified in Its Charter) Delaware 000-10093 59-1224913 (State or Other Jurisdiction of Incorporation)

FUSE MEDICAL, INC. FISCAL YEAR 2022 FINANCIAL RESULTS

Exhibit 99.1 FOR IMMEDIATE RELEASE Contact: Fuse Medical, Inc. Attention: Lawrence S. Yellin, Chief Financial Officer 1565 North Central Expressway, Suite 220 Richardson, Texas 75080 Office (469) 862-3030 Facsimile (469) 862-3035 [email protected] FUSE MEDICAL, INC. FISCAL YEAR 2022 FINANCIAL RESULTS April 18, 2023 RICHARDSON, TX,/Businesswire/ - Fuse Medical, Inc. (OTCPINK: FZMD) (“Fuse” or th

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 000-10093 Fuse Medical, Inc. (Exact name of registrant as specified i

Amendment No. 2, dated April 13, 2023, to Promissory Note dated May 6, 2020, by and between NC 143 Holdings, LP and Fuse Medical, Inc.

Exhibit 10.47 AMENDMENT NO. 2 TO PROMISSORY NOTE This Amendment No. 2 to Promissory Note (this “Amendment”), dated as of April 13, 2023 (the “Effective Date”), by and between FUSE MEDICAL, INC., a Delaware corporation (“Borrower”), and NC 143 FAMILY HOLDING, LP, a Texas limited partnership (“Lender”) amends the Promissory Note, dated May 6, 2020, issued by Borrow to Lender in principal sum of $180

Amendment No. 2, dated April 13, 2023, to Promissory Note dated May 6, 2020, by and between Reeg Medical Industries, Inc. and Fuse Medical, Inc.

Exhibit 10.48 AMENDMENT NO. 2 TO PROMISSORY NOTE This Amendment No. 2 to Promissory Note (this “Amendment”), dated as of April 13, 2023 (the “Effective Date”), by and between FUSE MEDICAL, INC., a Delaware corporation (“Borrower”), and REEG MEDICAL INDUSTRIES, INC., a Texas corporation (“Lender”) amends the Promissory Note, dated May 6, 2020, issued by Borrow to Lender in principal sum of $20,000.

List of Subsidiaries of Fuse Medical, Inc.

Exhibit 21.1 Fuse Medical, Inc. (A Delaware Corporation) List of Significant Subsidiaries (As of December 31, 2022) CPM Medical Consultants, LLC

First Amendment to Credit and Security Agreement Waiver dated March 22, 2023, between eCAPITAL HEALTHCARE CORP and Fuse Medical, Inc and CPM Medical Consultants

Exhibit 10.46 FIRST AMENDMENT TO CREDIT AND SECURITY AGREEMENT AND WAIVER This First Amendment to Credit and Security Agreement and Waiver (this “Agreement”) is dated as of March 22, 2023, and is by and between FUSE MEDICAL INC., a Delaware corporation, and CPM MEDICAL CONSULTANTS, LLC, a Texas limited liability company (individually and/or collectively, the “Borrower” and/or “Borrowers”), and eCA

UNITED STATES

UNITED STATES OMB APPROVAL SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 OMB Number: 3235-0058 Expires: April 30, 2025 Estimated average burden hours per response 2.50 FORM 12b-25 SEC FILE NUMBER NOTIFICATION OF LATE FILING CUSIP NUMBER (Check one): ☑ Form 10-K ☐ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form 10-D ☐ Form N-CEN ☐ Form N-CSR For Period Ended: December 31, 2022 ☐ Transition Rep

Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 22, 2022 (November 17, 2022) FUSE MEDICAL, INC. (Exact name of Registrant as Specified in Its Charter) Delaware 000-10093 59-1224913 (State or Other Jurisdiction of Incorpora

Letter from Armanino LLP dated November 21, 2022.

Exhibit 16.1 Armanino LLP 15950 N. Dallas Parkway Suite 600 Dallas, TX 75248-6685 972 661 1843 main armaninoLLP.com November 21, 2022 Securities and Exchange Commission 100 F Street N.E. Washington D.C. 20549-7561 We have read Fuse Medical, Inc.?s statements included in Item 4.01 of its Form 8-K dated November 22, 2022 and agree with those statements concerning our firm. /s/ Armanino LLP

FUSE MEDICAL, INC. ANNOUNCES THIRD QUARTER 2022 FINANCIAL RESULTS

FOR IMMEDIATE RELEASE Contact: Fuse Medical, Inc. Attention: Kenneth Walker, Sr. Investor Relations Analyst 1565 North Central Expressway, Suite 220 Richardson, Texas 75080 Office (469) 862-3030 Facsimile (469) 862-3035 [email protected] FUSE MEDICAL, INC. ANNOUNCES THIRD QUARTER 2022 FINANCIAL RESULTS November 15, 2022 RICHARDSON, TX, [DATE] /Businesswire/ - Fuse Medical, Inc. (OTCPINK: FZMD)

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 18, 2022 (November 15, 2022) FUSE MEDICAL, INC. (Exact name of Registrant as Specified in Its Charter) Delaware 000-10093 59-1224913 (State or Other Jurisdiction of Incorpora

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: September 30, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 000-10093 Fuse Medical, Inc. (Exact name of registrant as spec

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: June 30, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 000-10093 Fuse Medical, Inc. (Exact name of registrant as specified

Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 27, 2022 (June 23, 2022) FUSE MEDICAL, INC. (Exact name of Registrant as Specified in Its Charter) Delaware 000-10093 59-1224913 (State or Other Jurisdiction of Incorporation) (C

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: March 31, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 000-10093 Fuse Medical, Inc. (Exact name of registrant as specifie

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(A) OF THE SECURITIES EXCHANGE ACT OF 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(A) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ? Filed by a party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definitive Proxy State

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(A) OF THE SECURITIES EXCHANGE ACT OF 1934

DEF 14A 1 d487675ddef14a.htm DEF 14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(A) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 4, 2022 (April 4, 2022) FUSE MEDICAL, INC. (Exact name of Registrant as Specified in Its Charter) Delaware 000-10093 59-1224913 (State or Other Jurisdiction of Incorporation) (C

Amendment No. 1, dated March __, 2022, to Promissory Note dated May 6, 2020, by and between Reeg Medical Industries, Inc. and Fuse Medical, Inc.

Exhibit 10.43 AMENDMENT NO. 1 TO PROMISSORY NOTE This Amendment No. 1 to Promissory Note (this ?Amendment?), dated as of March 25, 2022 (the ?Effective Date?), by and between FUSE MEDICAL, INC., a Delaware corporation (?Borrower?), and REEG MEDICAL INDUSTRIES, INC., a Texas corporation (?Lender?) amends the Promissory Note, dated May 6, 2020, issued by Borrow to Lender in principal sum of $20,000.

Amendment No. 1, dated March __, 2022, to Promissory Note dated May 6, 2020, by and between NC 143 Holdings, LP and Fuse Medical, Inc.

Exhibit 10.41 AMENDMENT NO. 1 TO PROMISSORY NOTE This Amendment No. 1 to Promissory Note (this ?Amendment?), dated as of March 25, 2022 (the ?Effective Date?), by and between FUSE MEDICAL, INC., a Delaware corporation (?Borrower?), and NC 143 FAMILY HOLDING, LP, a Texas limited partnership (?Lender?) amends the Promissory Note, dated May 6, 2020, issued by Borrow to Lender in principal sum of $180

List of Subsidiaries of Fuse Medical, Inc

Exhibit 21.1 Fuse Medical, Inc. (A Delaware Corporation) List of Significant Subsidiaries (As of December 31, 2021) CPM Medical Consultants, LLC

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 000-10093 Fuse Medical, Inc. (Exact name of registrant as specified i

Credit and Security Agreement, dated December 14, 2021, by and between Fuse Medical, Inc., CPM Medical Consultants, LLC, as borrowers, and CNH Finance Fund 1, L.P., as lender (filed as Exhibit 10.1 to our company’s Form 8-K filed on December 20, 2021 and incorporated herein by reference).

Exhibit 10.1 CREDIT AND SECURITY AGREEMENT between FUSE MEDICAL, INC., AND THOSE ENTITIES LISTED ON SCHEDULE 1 HERETO each a Borrower and collectively the Borrowers and CNH FINANCE FUND I, L.P. as the Lender Dated as of December 14, 2021 Exhibit 10.1 CREDIT AND SECURITY AGREEMENT Table of Contents Page I. DEFINITIONS1 1.1 General Terms1 1.2 Specific Terms1 1.3 Other Definitional and Interpretative

Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 20, 2021 (December 14, 2021) FUSE MEDICAL, INC. (Exact name of Registrant as Specified in Its Charter) Delaware 000-10093 59-1224913 (State or Other Jurisdiction of Incorpora

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 29, 2021 FUSE MEDICAL, INC. (Exact name of Registrant as Specified in Its Charter) Delaware 000-10093 59-1224913 (State or Other Jurisdiction of Incorporation) (Commission Fi

Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 10, 2021 (November 10, 2021) FUSE MEDICAL, INC. (Exact name of Registrant as Specified in Its Charter) Delaware 000-10093 59-1224913 (State or Other Jurisdiction of Incorpora

Limited Waiver and Eighth Amendment to Amended and Restated Business Loan Agreement, dated November 4, 2021, by and between Zions Bancorporation, N.A. dba Amegy Bank, as “Lender”, and Fuse Medical, Inc. and CPM Medical Consultants, LLC, as “Borrowers”.

SMRH 11/10/21 LIMITED WAIVER AND EIGHTh AMENDMENT TO amended and restated business loan agreement This LIMITED WAIVER AND EIGHTH AMENDMENT TO AMENDED AND RESTATED BUSINESS LOAN AGREEMENT (this ?Amendment?), dated November 4, 2021 (the ?Amendment Effective Date?), is made and entered into by and among Zions Bancorporation, N.

Limited Waiver to Amended and Restated Business Loan Agreement dated November 8, 2021 by and between Zions Bancorporation, N.A. (dba Amegy Bank) and Fuse Medical, Inc

Exhibit 10.1 November 8, 2021 Mr. Bill McLaughlin Fuse Medical, Inc. 1565 N Central Expy Ste. 200 Richardson, TX Re:Fuse Medical, Inc. Loan Agreement Dear Mr. McLaughlin, Fuse Medical, Inc. is in default of the above-referenced indebtedness pursuant to the terms of the Note and other documents evidencing, securing or pertaining to the indebtedness. The default arose from non-compliance with the mi

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: September 30, 2021 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 000-10093 Fuse Medical, Inc. (Exact name of registrant as spec

Limited Waiver to Amended and Restated Business Loan Agreement dated August 4, 2021 by and between Zions Bancorporation, N.A. (dba Amegy Bank) and Fuse Medical, Inc.

Amegy Bank? ofTexas P.O. Bo x 650696 ? Dallas, Texas 75265-0696 www .amegybank.com August 4, 2021 Mr. Bill McLaughlin Fuse Medical, Inc. 1565 N Central Expy Ste. 200 Richardson, TX Re:Fuse Medical, Inc. Loan Agreement Dear Mr. McLaughlin, Fuse Medical, Inc. is in default of the above-referenced indebtedness pursuant to the terms of the Note and other documents evidencing, securing or pertaining to

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: June 30, 2021 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 000-10093 Fuse Medical, Inc. (Exact name of registrant as specified

Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 10, 2021 (June 9, 2021) FUSE MEDICAL, INC. (Exact name of Registrant as Specified in Its Charter) Delaware 000-10093 59-1224913 (State or Other Jurisdiction of Incorporation) (Co

Limited Waiver and Seventh Amendment to Amended and Restated Business Loan Agreement dated May 4, 2021, by and between Zions Bancorporation, N.A. (dba Amegy Bank) and Fuse Medical, Inc. and CPM Medical Consultants, LLC.

EX-10.1 2 fzmd-ex101333.htm EX-10.1 EXHIBIT 10.1 LIMITED WAIVER AND SEVENTH AMENDMENT TO AMENDED AND RESTATED BUSINESS LOAN AGREEMENT This LIMITED WAIVER AND SEVENTH AMENDME T TO AMENDED AND RESTATED BUSINESS LOAN AGREEMENT (this "Amendment"), dated May 4, 2021 (the " Amendment Effective Date"), is made and entered into by and among Zions Bancorporation, N.A. dba Amegy Bank (together with its succ

Amendment to the Stocking and Subdistribution Agreement dated April 22, 2021, by and between Texas Overlord, LLC and CPM Medical Consultants, LLC.

CPM MEDICAL CONSULTANTS, LLC AMENDMENT TO THE STOCKING AND SUBDISTRIBUTION AGREEMENT This amendment to the stocking and subdistribution agreement ("Amendment"), dated as of November 1st, 2020 (" Effective Date") , is entered into by and between CPM Medical Consultants, LLC, a Texas Limited Liability Company having its principal place of business at 1565 N.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: March 31, 2021 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 000-10093 Fuse Medical, Inc. (Exact name of registrant as specifie

- DEF 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(A) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ? Filed by a party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definitive Proxy State

- DEFA14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(A) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ? Filed by a party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definitive Proxy State

Annual Report - 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 000-10093 Fuse Medical, Inc. (Exact name of registrant as specified i

List of Subsidiaries of Fuse Medical, Inc.

Exhibit 21.1 Fuse Medical, Inc. (A Delaware Corporation) List of Significant Subsidiaries (As of December 31, 2019) CPM Medical Consultants, LLC Palm Springs Partners, LLC D/B/A Maxim Surgical

Amendment to the Stocking and Distribution, dated February 24, 2020, by and between CPM Medical Consultants, LLC and MedUSA Group, LLC.

Exhibit 10.21 CPM MEDICAL CONSULTANTS, LLC AMENDMENT TO THE STOCKING AND SUBDISTRIBUTION AGREEMENT This amendment to the stocking and subdistribution agreement ("Amendment"), dated as of January 1st, 2020 ("Effective Date"), is entered into by and between CPM Medical Consultants, LLC, a Texas Limited Liability Company having its principal place of business at 1565 N. Central Expressway, Suite 200,

FUSE MEDICAL, INC. ANNOUNCES EXCLUSIVE AGREEMENT WITH ORTHOVESTMENTS, LLC FOR MANUFACTURING & COMMERCIALIZATION OF THE ORBITUM ™ STAPLE SYSTEM

For Immediate Release Contact: Fuse Medical, Inc. Attention: Devon Morgan, Sr. Investor Relations Analyst 1565 North Central Expressway, Suite 220 Richardson, Texas 75080 Office (469) 862-3030 Facsimile (469) 862-3035 [email protected] FUSE MEDICAL, INC. ANNOUNCES EXCLUSIVE AGREEMENT WITH ORTHOVESTMENTS, LLC FOR MANUFACTURING & COMMERCIALIZATION OF THE ORBITUM ™ STAPLE SYSTEM RICHARDSON, TX, Fe

Financial Statements and Exhibits, Other Events - 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 1, 2021 (February 1, 2021) FUSE MEDICAL, INC. (Exact name of Registrant as Specified in Its Charter) Delaware 000-10093 59-1224913 (State or Other Jurisdiction of Incorporati

Financial Statements and Exhibits, Other Events - 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 20, 2021 (January 14, 2021) FUSE MEDICAL, INC. (Exact name of Registrant as Specified in Its Charter) Delaware 000-10093 59-1224913 (State or Other Jurisdiction of Incorporati

FUSE MEDICAL, INC. ENTERS INTO MARKETING AGREEMENT WITH CAREPICS TELEHEALTH

Exhibit 99.1 For Immediate Release Contact: Fuse Medical, Inc. Attention: Devon Morgan, Sr. Investor Relations Analyst 1565 North Central Expressway, Suite 220 Richardson, Texas 75080 Office (469) 862-3030 Facsimile (469) 862-3035 [email protected] FUSE MEDICAL, INC. ENTERS INTO MARKETING AGREEMENT WITH CAREPICS TELEHEALTH RICHARDSON, TX, January 14, 2021 /Businesswire/ - Fuse Medical, Inc. (OT

Financial Statements and Exhibits, Other Events - 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 22, 2020 (December 22, 2020) FUSE MEDICAL, INC. (Exact name of Registrant as Specified in Its Charter) Delaware 000-10093 59-1224913 (State or Other Jurisdiction of Incorpora

FUSE MEDICAL, INC. ANNOUNCES LAUNCH OF FuseChoiceTM BIOLOGICS PORTFOLIO

For Immediate Release Contact: Fuse Medical, Inc. Attention: Devon Morgan, Sr. Investor Relations Analyst 1565 North Central Expressway, Suite 220 Richardson, Texas 75080 Office (469) 862-3030 Facsimile (469) 862-3035 [email protected] FUSE MEDICAL, INC. ANNOUNCES LAUNCH OF FuseChoiceTM BIOLOGICS PORTFOLIO RICHARDSON, TX, December 22, 2020 /Businesswire/ - Fuse Medical, Inc. (OTCPINK: FZMD) (“F

Limited Waiver and Sixth Amendment to Amended and Restated Business Loan Agreement, dated November 19, 2018, by and among ZB, N.A. (D/B/A Amegy Bank), Fuse Medical, Inc. and CPM Medical Consultants, LLC (filed as 10.1 to our Company’s Form 10-Q filed on November 16, 2020 and incorporated herein by reference).

Execution Version SIXTH AMENDMENT TO AMENDED AND RESTATED BUSINESS LOAN AGREEMENT This SIXTH AMENDMENT TO AMENDED AND RESTATED BUSINESS LOAN AGREEMENT (this ?Amendment"), dated November 12, 2020 (the "Amendment Effective Date"), is made and entered into by and among Zions Bancorporation, N.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: September 30, 2020 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 000-10093 Fuse Medical, Inc. (Exact name of registrant as spec

FUSE MEDICAL, INC. FILES QUARTERLY RESULTS ON FORM 10-Q AND PROVIDES BUSINESS UPDATE IN RESPONSE OF COVID-19

Exhibit 99.1 For Immediate Release Contact: Fuse Medical, Inc. Attention: Devon Morgan, Sr. Investor Relations Analyst 1565 North Central Expressway, Suite 220 Richardson, Texas 75080 Office (469) 862-3030 Facsimile (469) 862-3035 [email protected] FUSE MEDICAL, INC. FILES QUARTERLY RESULTS ON FORM 10-Q AND PROVIDES BUSINESS UPDATE IN RESPONSE OF COVID-19 RICHARDSON, TX, August 10, 2020 /Busine

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 14, 2020 (August 10, 2020) FUSE MEDICAL, INC. (Exact name of Registrant as Specified in Its Charter) Delaware 000-10093 59-1224913 (State or Other Jurisdiction of Incorporation

FUSE MEDICAL, INC. RANKED AMONG TOP 150 PUBLIC COMPANIES IN DALLAS- FORT WORTH METROPLEX

EX-99.2 3 fzmd-ex9929.htm EX-99.2 Exhibit 99.2 For Immediate Release Contact: Fuse Medical, Inc. Attention: Devon Morgan, Sr. Investor Relations Analyst 1565 North Central Expressway, Suite 220 Richardson, Texas 75080 Office (469) 862-3030 Facsimile (469) 862-3035 [email protected] FUSE MEDICAL, INC. RANKED AMONG TOP 150 PUBLIC COMPANIES IN DALLAS- FORT WORTH METROPLEX RICHARDSON, TX, August 14

Promissory Note dated May 6, 2020, by and between NC 143 Holdings, LP and Fuse Medical, Inc. (filed as Exhibit 10.3 to our Company’s Form 10-Q filed on August 7, 2020 and incorporated herein by reference).

PROMISSORY NOTE $180,000.00 May 6, 2020 FOR VALUE RECEIVED, FUSE MEDICAL, INC., a Delaware corporation ("Borrower"), whose address is 1565 North Central Expressway, Suite 220, Richardson, Texas 75080, promises to pay to the order of NC 143 FAMILY HOLDING, LP, a Texas limited partnership ("Lender"), at 1565 North Central Expressway, 2nd Floor, Richardson, TX 75080 c/o Mark W. Brooks, Fuse Medical,

Economic Injury Disaster Loan Agreement dated May 12, 2020 by and between the U.S. Small Business Administration and Fuse Medical, Inc. (filed as Exhibit 10.2 to our Company’s Form 10-Q filed on August 7, 2020 and incorporated herein by reference).

Doc # L-01-2676051-01 DocuSign Envelope ID: 46F60A33-FA46-47BB-B61E-D687E31EBC0D SBA Loan #5146047404 Application #3304117588 LOAN AUTHORIZATION AND AGREEMENT (LA&A) A PROPERLY SIGNED DOCUMENT IS REQUIRED PRIOR TO ANY DISBURSEMENT CAREFULLY READ THE LA&A: This document describes the terms and conditions of your loan.

Quarterly Report - 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: June 30, 2020 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 000-10093 Fuse Medical, Inc. (Exact name of registrant as specified

Promissory Note dated May 6, 2020, by and between Reeg Medical Industries, Inc. and Fuse Medical, Inc. (filed as Exhibit 10.4 to our Company’s Form 10-Q filed on August 7, 2020 and incorporated herein by reference).

PROMISSORY NOTE $20,000.00 May 6, 2020 FOR VALUE RECEIVED, FUSE MEDICAL, INC., a Delaware corporation ("Borrower"), whose address is 1565 North Central Expressway, Suite 220, Richardson, Texas 75080, promises to pay to the order of REEG MEDICAL INDUSTRIES, INC., a Texas corporation ("Lender"), at 3024 Westminster Avenue, Dallas, Texas 75205 c/o Christopher C. Reeg, Fuse Medical, Inc. Chief Executi

Letter from Baker Tilly Virchow Krause, LLP dated June 19, 2020.

Baker Tilly Virchow Krause, LLP 2500 Dallas Parkway; Ste 300 Plano, TX 75093 United States of America T: +1 (972) 748 0300 F: +1 (972) 748 0700 bakertilly.

FUSE MEDICAL, INC. ANNOUNCES ENGAGEMENT OF ARMANINO LLP

For Immediate Release Contact: Fuse Medical, Inc. Attention: Devon Morgan, Sr. Investor Relations Analyst 1565 North Central Expressway, Suite 220 Richardson, Texas 75080 Office (469) 862-3030 Facsimile (469) 862-3035 [email protected] FUSE MEDICAL, INC. ANNOUNCES ENGAGEMENT OF ARMANINO LLP RICHARDSON, TX, June 19, 2020 /Businesswire/ - Fuse Medical, Inc. (OTCPINK: FZMD) (“Fuse” or the “Company

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 19, 2020 (June 15, 2020) FUSE MEDICAL, INC. (Exact name of Registrant as Specified in Its Charter) Delaware 000-10093 59-1224913 (State or Other Jurisdiction of Incorporation) (C

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 10, 2020 (June 9, 2020) FUSE MEDICAL, INC. (Exact name of Registrant as Specified in Its Charter) Delaware 000-10093 59-1224913 (State or Other Jurisdiction of Incorporation) (Co

Limited Waiver and Fifth Amendment to Amended and Restated Business Loan Agreement, dated November 19, 2018, by and among ZB, N.A. (D/B/A Amegy Bank), Fuse Medical, Inc., and CPM Medical Consultants, LLC (filed as Exhibit 10.1 to our Company’s Form 10-Q filed on May 22, 2020 and incorporated herein by reference).

EXHIBIT 10.1 Execution Version LIMITED WAIVER AND FIFTH AMENDMENT TO AMENDED AND RESTATED BUSINESS LOAN AGREEMENT This LIMITED WAIVER AND FIFTH AMENDMENT TO AMENDED AND RESTATED BUSINESS LOAN AGREEMENT (this “Amendment”), dated May 21, 2020 (the “Fifth Amendment Effective Date”), is made and entered into by and among Zions Bancorporation, N.A. dba Amegy Bank (together with its successors and assig

Paycheck Protection Program Promissory Note dated April 15, 2020, by and between ZB, N.A. (D/B/A Amegy Bank) Fuse Medical, Inc. and CPM Medical Consultants, LLC (filed as Exhibit 10.2 to our Company’s Form 10-Q filed on May 22, 2020 and incorporated herein by reference).

THIS IS A COPY The Authoritative Copy of this record is held at NA3.docusign.net DocuSign Envelope ID: 66F247CA-1C44-4CFA-A9E5-6EECBEF4CFF4 EXHIBIT 10.2 This Statement of Policy is Posted In Accordance with Regulations of the Small Business Administration This Organization Practices Equal Employment Opportunity We do not discriminate on the ground of race, color, religion, sex, age, disablity or n

Quarterly Report - 10-Q_2020-3-31

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: March 31, 2020 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 000-10093 Fuse Medical, Inc. (Exact name of registrant as specifie

- NT 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One) ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: March 31, 2020 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form 10-Q ☐ Transition Report on Fo

Promissory Note, dated May 6, 2020, by and between Reeg Medical Industries, Inc. as “Lender”, and Fuse Medical, Inc. as “Borrower”.

PROMISSORY NOTE $20,000.00 May 6, 2020 FOR VALUE RECEIVED, FUSE MEDICAL, INC., a Delaware corporation ("Borrower"), whose address is 1565 North Central Expressway, Suite 220, Richardson, Texas 75080, promises to pay to the order of REEG MEDICAL INDUSTRIES, INC., a Texas corporation ("Lender"), at 3024 Westminster Avenue, Dallas, Texas 75205 c/o Christopher C. Reeg, Fuse Medical, Inc. Chief Executi

Promissory Note, dated May 6, 2020, by and between NC 143 Family Holdings, LP as “Lender”, and Fuse Medical, Inc. as “Borrower”.

PROMISSORY NOTE $180,000.00 May 6, 2020 FOR VALUE RECEIVED, FUSE MEDICAL, INC., a Delaware corporation ("Borrower"), whose address is 1565 North Central Expressway, Suite 220, Richardson, Texas 75080, promises to pay to the order of NC 143 FAMILY HOLDING, LP, a Texas limited partnership ("Lender"), at 1565 North Central Expressway, 2nd Floor, Richardson, TX 75080 c/o Mark W. Brooks, Fuse Medical,

Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 12, 2020 (May 6, 2020) FUSE MEDICAL, INC. (Exact name of Registrant as Specified in Its Charter) Delaware 000-10093 59-1224913 (State or Other Jurisdiction of Incorporation) (Comm

- DEFA14A

DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(A) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Pro

- DEF 14A

DEF 14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.

List of Subsidiaries of Fuse Medical, Inc.

EX-21.1 3 fzmd-ex21111.htm EX-21.1 Exhibit 21.1 Fuse Medical, Inc. (A Delaware Corporation) List of Significant Subsidiaries (As of December 31, 2019) CPM Medical Consultants, LLC Palm Springs Partners, LLC D/B/A Maxim Surgical

Amendment to the Stocking and Distribution, dated February 24, 2020, by and between CPM Medical Consultants, LLC and MedUSA Group, LLC. (filed as Exhibit 10.21 to the Company’s Form 10-K, filed on March 31, 2021 and incorporated herein by reference).

Exhibit 10.21 CPM MEDICAL CONSULTANTS, LLC AMENDMENT TO THE STOCKING AND SUBDISTRIBUTION AGREEMENT This amendment to the stocking and subdistribution agreement ("Amendment"), dated as of January 1st, 2020 ("Effective Date"), is entered into by and between CPM Medical Consultants, LLC, a Texas Limited Liability Company having its principal place of business at 1565 N. Central Expressway, Suite 200,

FZMD / Fuse Medical, Inc. 10-K - Annual Report - 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 000-10093 Fuse Medical, Inc. (Exact name of registrant as specified i

Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 20, 2019 (December 18, 2019) FUSE MEDICAL, INC. (Exact name of Registrant as Specified in Its Charter) Delaware 000-10093 59-1224913 (State or Other Jurisdiction of Incorpora

Limited Waiver and Fourth Amendment to Amended and Restated Business Loan Agreement, dated November 19, 2018, by and among ZB, N.A. (D/B/A Amegy Bank), Fuse Medical, Inc., and CPM Medical Consultants, LLC (filed as Exhibit 10.5 to our company’s Form 8-K filed on December 20, 2019 and incorporated herein by reference).

Exhibit 10.5 Execution Version LIMITED WAIVER AND FOURTH AMENDMENT TO AMENDED AND RESTATED BUSINESS LOAN AGREEMENT This LIMITED WAIVER AND FOURTH AMENDMENT TO AMENDED AND RESTATED BUSINESS LOAN AGREEMENT (this "Amendment"), dated as December 18, 2019 ("Fourth Amendment Effective Date"), is made and entered into by and among Zions Bancorporation, N.A. dba Amegy Bank (together with its successors an

FZMD / Fuse Medical, Inc. 10-Q - Quarterly Report - 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: September 30, 2019 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 000-10093 Fuse Medical, Inc. (Exact name of registrant as spec

Waiver Agreement dated November 13, 2019, by and between Zions Bancorporation, N.A. dba Amegy Bank and Fuse Medical, Inc. and CPM Medical Consultants, LLC.

EXHIBIT 10.1 November 13, 2018 Mr. Bill McLaughlin Fuse Medical, Inc. 1565 N Central Expy Ste. 200 Richardson, TX Re: Fuse Medical, Inc. Loan Agreement amended and restated as-of 12/3 I/20I 7, associated with note in the original principal amount of$5,000,000 (the "Note") due and unpaid to ZB, NA. dba Amegy Bank (the "Bank") Dear Mr. McLaughlin, Fuse Medical, Inc. is in default of the above-refere

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 28, 2019 (October 23, 2019) FUSE MEDICAL, INC. (Exact name of Registrant as specified in its charter) Delaware 000-10093 59-1224913 (State or other jurisdiction of incorporati

FZMD / Fuse Medical, Inc. 10-Q - Quarterly Report - 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: June 30, 2019 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 000-10093 Fuse Medical, Inc. (Exact name of registrant as specified

FZMD / Fuse Medical, Inc. 10-Q/A - Quarterly Report - 10-Q/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A Amendment No. 1 ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: March 31, 2019 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 000-10093 Fuse Medical, Inc. (Exact name of regi

Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 27, 2019 (June 26, 2019) FUSE MEDICAL, INC. (Exact name of Registrant as specified in its charter) Delaware 000-10093 59-1224913 (State or other jurisdiction of incorpor

FUSE MEDICAL ANNOUNCES 2019 ANNUAL SHAREHOLDER MEETING RESULTS

EX-99.1 Exhibit 99.1 For Immediate Release Contact: Fuse Medical, Inc. Attention: Devon Morgan, Sr. Investor Relations Analyst 1565 North Central Expressway, Suite 220 Richardson, Texas 75080 Office (469) 862-3030 Facsimile (469) 862-3035 [email protected] FUSE MEDICAL ANNOUNCES 2019 ANNUAL SHAREHOLDER MEETING RESULTS RICHARDSON, TX, June 27, 2019 /Businesswire/ — Fuse Medical, Inc., (OTCPK: FZ

FZMD / Fuse Medical, Inc. DEFA14A - - DEFA14A

DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Pro

Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 5, 2019 (June 1, 2019) FUSE MEDICAL, INC. (Exact name of Registrant as specified in its charter) Delaware 000-10093 59-1224913 (State or other jurisdiction of incorporat

Letter from MCG dated June 5, 2019.

EX-16.1 Exhibit 16.1 MONTGOMERY COSCIA GREILICH LLP 972.748.0300 p 972.748.0700 f INDEPENDENT AUDITORS’ REPORT June 5, 2019 Securities and Exchange Commission 100 F Street, NE Washington, DC 20549 Dear Ladies and Gentlemen: We are the former independent registered public accounting firm for Fuse Medical, Inc. (the “Company”). We have read the Company’s disclosure set forth in Item 4.01 “Changes in

FZMD / Fuse Medical, Inc. DEFA14A DEFA14A

DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(A) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Pro

FZMD / Fuse Medical, Inc. DEF 14A DEF 14A

DEF 14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.

Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 10, 2019 (May 9, 2019) FUSE MEDICAL, INC. (Exact name of Registrant as specified in its charter) Delaware 000-10093 59-1224913 (State or other jurisdiction of incorporati

Limited Waiver and Third Amendment to Amended and Restated Business Loan Agreement, dated November 19, 2018, by and among ZB, N.A. (D/B/A Amegy Bank), Fuse Medical, Inc., and CPM Medical Consultants, LLC (filed as Exhibit 10.4 to our company’s Form 8-K filed on May 13, 2019 and incorporated herein by reference).

EX-10.4 2 d743757dex104.htm EX-10.4 Exhibit 10.4 LIMITED WAIVER AND THIRD AMENDMENT TO AMENDED AND RESTATED BUSINESS LOAN AGREEMENT This LIMITED WAIVER AND THIRD AMENDMENT TO AMENDED AND RESTATED BUSINESS LOAN AGREEMENT (this “Amendment”), dated as May 9, 2019 (“Third Amendment Effective Date”), is made and entered into by and among Zions Bancorporation, N.A. dba Amegy Bank (together with its succ

Financial Statements and Exhibits, Other Events

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 9, 2019 (May 8, 2019) FUSE MEDICAL, INC. (Exact name of Registrant as specified in its charter) Delaware 000-10093 59-1224913 (State or other jurisdiction of incorporatio

FUSE MEDICAL REPORTS FIRST QUARTER 2019 RESULTS

EX-99.1 Exhibit 99.1 For Immediate Release Contact: Fuse Medical, Inc. Attention: Devon Morgan, Sr. Investor Relations Analyst 1565 North Central Expressway, Suite 220 Richardson, Texas 75080 Office (469) 862-3030 Facsimile (469) 862-3035 [email protected] FUSE MEDICAL REPORTS FIRST QUARTER 2019 RESULTS RICHARDSON, TX, May 8, 2019 /Businesswire/ — Fuse Medical, Inc., (OTCPK: FZMD), a distributo

FZMD / Fuse Medical, Inc. 10-Q Quarterly Report 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: March 31, 2019 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 000-10093 Fuse Medical, Inc. (Exact name of registrant as specifie

FZMD / Fuse Medical, Inc. PRE 14A PRELIMINARY PROXY STATEMENT

Preliminary Proxy Statement Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.

Waiver Agreement dated April 26, 2019, by and between Zions Bancorporation, N.A. (dba Amegy Bank and Fuse Medical, Inc. and CPM Medical Consultants, LLC, incorporated herein by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the SEC on April 30, 2019.

EX-10.1 Exhibit 10.1 April 26, 2019 Mr. Bill McLaughlin, CFO Fuse Medical, Inc. 1565 N Central Expy Ste. 200 Richardson, TX Re: Fuse Medical, Inc. Loan Agreement amended and restated as-of 12/31/2017, associated with note in the original principal amount of $5,000,000 (the “Note”) due and unpaid to ZB, N.A. dba Amegy Bank (the “Bank”) and First amendment to amended and restated business loan agree

Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 30, 2019 (April 26, 2019) FUSE MEDICAL, INC. (Exact name of Registrant as specified in its charter) Delaware 000-10093 59-1224913 (State or other jurisdiction of incorp

FUSE MEDICAL REPORTS FULL YEAR 2018 FINANCIAL RESULTS WITH RECORD EARNINGS

EX-99.1 Exhibit 99.1 For Immediate Release Contact: Fuse Medical, Inc. Attention: Devon Morgan, Senior Investor Relations Analyst 1565 North Central Expressway, Suite 220 Richardson, Texas 75080 Office (469) 862-3030 Facsimile (469) 862-3035 [email protected] FUSE MEDICAL REPORTS FULL YEAR 2018 FINANCIAL RESULTS WITH RECORD EARNINGS RICHARDSON, TX, March 25, 2019 /Businesswire/ — Fuse Medical,

Financial Statements and Exhibits, Other Events

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 25, 2019 (March 21, 2019) FUSE MEDICAL, INC. (Exact name of Registrant as specified in its charter) Delaware 000-10093 59-1224913 (State or other jurisdiction of incorp

Amended and Restated Bylaws of Fuse Medical, Inc., incorporated herein by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed with the SEC on March 21, 2019.

EX-3.1 Exhibit 3.1 AMENDED AND RESTATED BY-LAWS OF FUSE MEDICAL, INC. ADOPTED BY THE BOARD OF FUSE MEDICAL, INC. ON MARCH 20, 2019 ARTICLE 1 OFFICES 1 Section 1.01 Registered Office 1 Section 1.02 Other Offices 1 ARTICLE 2 MEETINGS OF THE STOCKHOLDERS 1 Section 2.01 Place of Meetings 1 Section 2.02 Annual Meeting 1 Section 2.03 Special Meetings 1 Section 2.04 Adjournments 3 Section 2.05 Notice of

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 21, 2019 (March 20, 2019) FUSE MEDICAL, INC. (Exact name of Registrant as specified in its charter) Delaware 000-10093 59-1224913 (State or other jurisdiction of incorp

Sales Agency Agreement, dated August 1, 2018, by and between CPM Medical Consultants, LLC and StelKast, Inc.

EXHIBIT 10.25 SALES AGENCY AGREEMENT THIS SALES AGENCY AGREEMENT (this “Agreement”) is made this 1st day of August 2018, by and between StelKast, Inc., a Pennsylvania corporation (“StelKast”), and CPM Medical Consultants, LLC, an independent sales representative with its principal office located at 1565 N. Central Expy., Suite 200, Richardson, TX 75080, (“Agent”). NOW, THEREFORE, in consideration

Stocking and Distribution Agreement, dated November 1, 2017, by and between CPM Medical Consultants, LLC and Ununtrium, LLC.

EX-10.62 52 fzmd-ex1062110.htm EX-10.62 EXHIBIT 10.62 CPM MEDICAL CONSULTANTS, LLC STOCKING AND SUBDISTRIBUTION AGREEMENT THIS STOCKING AND SUBDISTRIBUTION AGREEMENT, dated as of November 1st, 2017 (the “Agreement”), is entered into by and between CPM Medical Consultants, LLC, a Texas Limited Liability Company having its principal place of business at 1565 N. Central Expressway, Suite 200, Richard

Stocking and Distribution Agreement, dated November 1, 2017, by and between CPM Medical Consultants, LLC and Bio-Ortho, LLC.

EXHIBIT 10.61 CPM MEDICAL CONSULTANTS, LLC STOCKING AND SUBDISTRIBUTION AGREEMENT THIS STOCKING AND SUBDISTRIBUTION AGREEMENT, dated as of November 1st, 2017 (the “Agreement”), is entered into by and between CPM Medical Consultants, LLC, a Texas Limited Liability Company having its principal place of business at 1565 N. Central Expressway, Suite 200, Richardson, TX 75080 (“Distributor”), and Bio-O

Commercial Property Lease Agreement dated January 1, 2013 by and between CPM Medical Consultants, LLC and 1565 North Central Expressway, LP. (filed as Exhibit 10.4 to the Company’s Form 10-K, filed on March 21, 2019 and incorporated herein by reference).

EX-10.4 2 fzmd-ex104126.htm EX-10.4 EXHIBIT 10.4 Net Lease for Entire Building 1. Names. This lease is made by 1565 N. Central Expressway, LP, Landlord, and CPM Medical Consultants, LLC, Tenant. 2. Premises Being Leased. Landlord is leasing to Tenant and Tenant is leasing from Landlord the following premises: 1565 N. Central Expressway, 2nd Floor, Richardson, TX 75080 3. Term of Lease. This lease

Amendment Number 2 to Distribution Agreement, dated October 31, 2012, by and between CPM Medical Consultants, LLC and Arteriocyte Medical Systems, Inc.

EXHIBIT 10.37 Second Amendment to the Distribution Agreement This Second Amendment to the Distribution Agreement ("the Amendment") entered into on October 31, 2012 by and between Arteriocyte Medical Systems, Inc. (the "Company"), a Delaware Corporation and CPM Medical, Inc. (the "Distributor") (collectively, "the Parties"), a Texas Corporation, modifies the Distribution Agreement by and between th

Distributor Agreement, dated October 26, 2016, by and between CPM Medical Consultants, LLC and Vilex in Tennessee, Inc. D/B/A Vilex, Inc.

EXHIBIT 10.33 DISTRIBUTOR AGREEMENT This Agreement is entered into to be effective as of October 26, 2016 by and between Vilex in Tennessee, Inc. (DBA: Vilex, Inc.) located at 111 Moffitt Street, McMinnville, TN 37110 USA (“Company”) and CPM Medical Consultants, LLC, a Texas Limited Liability Company, located at 1565 N. Central Expressway, Suite 200, Richardson, TX 75080 (“Distributor”). RECITALS:

Distributor Purchase and Sales Agreement, dated January 27, 2015, by and between CPM Medical Consultants, LLC and Precision Spine, Inc. (filed as Exhibit 10.27 to the Company’s Form 10-K, filed on March 21, 2019 and incorporated herein by reference).

EX-10.27 17 fzmd-ex102797.htm EX-10.27 EXHIBIT 10.27 PRECISION SPINE, INC. DISTRIBUTOR PURCHASE AND SALES AGREEMENT AGREEMENT No 01272015-001 This Agreement is dated as of, January 27, 2015 by and between Precision Spine Inc. having an address at 5 Sylvan Way, Suite 220, Parsippany, NJ 07054 ("Precision") and CPM Medical, (hereinafter referred to as "Distributor"), having an address at 1565 N. Cen

Amendment Number 2 to Spinal Fusion Purchasing Agreement, dated June 2, 2017, by and between CPM Medical Consultants, LLC and Texas Health Resources.

EXHIBIT 10.23 Addendum to the Spinal Fusion Purchase Agreement between Texas Health Resources and CPM Medical June 2, 2017 The Agreement to which this Addendum is attached and incorporated and is executed by and between CPM Medical ("Vendor"), and Texas Health Resources with its principal place of business at 612 East Lamar Blvd., Suite 1100, Arlington, Texas 76011 ("Customer"), dated as of the da

Stocking and Distribution Agreement, dated November 1, 2017, by and between CPM Medical Consultants, LLC and MedUSA Group, LLC. (filed as Exhibit 10.48 to the Company’s Form 10-K, filed on March 21, 2019 and incorporated herein by reference).

EXHIBIT 10.48 CPM MEDICAL CONSULTANTS, LLC STOCKING AND SUBDISTRIBUTION AGREEMENT THIS STOCKING AND SUBDISTRIBUTION AGREEMENT, dated as of November 1st, 2017 (the “Agreement”), is entered into by and between CPM Medical Consultants, LLC, a Texas Limited Liability Company having its principal place of business at 1565 N. Central Expressway, Suite 200, Richardson, TX 75080 (“Distributor”), and MedUS

Services Agreement, dated January 1, 2014, by and between CPM Medical Consultants, LLC and Palm Springs Partners D/B/A Maxim Surgical, LLC.

EXHIBIT 10.54 SERVICES AGREEMENT This SERVICES AGREEMENT (“Agreement”) is made as of January 1, 2014, by and between CPM Medical Consultants, LLC (“CPM”) and Palm Springs Partners, LLC D/B/A Maxim Surgical (“Maxim”). The foregoing parties to this Agreement are sometimes referred to herein collectively as the “Parties” and each individually as a “Party”. NOW, THEREFORE, in consideration of the fore

List of Subsidiaries of Fuse Medical, Inc.

EX-21.1 55 fzmd-ex211127.htm EX-21.1 Exhibit 21.1 Fuse Medical, Inc. (A Delaware Corporation) List of Significant Subsidiaries (As of December 31, 2018) CPM Medical Consultants, LLC Palm Springs Partners D/B/A Maxim Surgical, LLC

Stocking and Distribution Agreement, dated January 1, 2018, by and between CPM Medical Consultants, LLC and Sintu, LLC. (filed as Exhibit 10.58 to the Company’s Form 10-K, filed on March 21, 2019 and incorporated herein by reference).

EXHIBIT 10.58 CPM MEDICAL CONSULTANTS, LLC STOCKING AND SUBDISTRIBUTION AGREEMENT THIS STOCKING AND SUBDISTRIBUTION AGREEMENT, dated as of January 1, 2018 (the “Agreement”), is entered into by and between CPM Medical Consultants, LLC, a Texas Limited Liability Company having its principal place of business at 1565 N. Central Expressway, Suite 200, Richardson, TX 75080 (“Distributor”), and Sintu, L

Distributorship Agreement, dated September 17, 2014, by and between CPM Medical Consultants, LLC and Amendia, Inc.

EXHIBIT 10.34 DISTRIBUTORSHIP AGREEMENT This Distributorship Agreement (this "Agreement"), effective the 17th day of September, 2014 (the "Effective Date"), is by and between Amendia, Inc., a Georgia corporation ("Supplier"), and CPM Medical Consultants, LLC ("Distributor" and, along with Supplier, the "Parties" and each a "Party"). This Agreement will not bind or be enforceable against Supplier u

Distributor Agreement, dated November 9, 2015, by and between CPM Medical Consultants, LLC and Corelink, LLC.

EX-10.32 22 fzmd-ex103291.htm EX-10.32 EXHIBIT 10.32 DISTRIBUTOR AGREEMENT THIS DISTRIBUTOR AGREEMENT (this "Agreement") is made effective as of November 9th, 2015, by and between CPM Medical Consultants LLC, a Texas Incorporation ("Distributor"), and CORELINK, LLC, a Missouri limited liability company ("CoreLink"). Distributor and CoreLink are each individually referred to herein as a "Party" and

Stocking and Distribution Agreement, dated December 1, 2017, by and between CPM Medical Consultants, LLC and Amnio Regen Solutions.

EX-10.24 14 fzmd-ex102474.htm EX-10.24 EXHIBIT 10.24 CPM MEDICAL CONSULTANTS, LLC STOCKING AND SUBDISTRIBUTION AGREEMENT THIS STOCKING AND SUBDISTRIBUTION AGREEMENT, dated as of December 1st, 2017 (the “Agreement”), is entered into by and between CPM Medical Consultants, LLC, a Texas Limited Liability Company having its principal place of business at 1565 N. Central Expressway, Suite 200, Richards

Biologics Purchasing Agreement, dated June 1, 2015, by and between CPM Medical Consultants, LLC and North Texas Division, Inc., D/B/A Medical City Healthcare.

EXHIBIT 10.16 PURCHASING AGREEMENT Products Division:North Texas Division, Inc. Vendor:CPM Medical Products:BIOLOGICS Effective Date:June 1, 2015 Agreement Number:NTD-5086 Template Version: November 10, 2010 Draft Date: Table of Contents 1.0 Definitions1 2.0 General Purchasing Provisions4 3.0 Rebates, Reporting, Prices, Payments6 4.0 EDI and E-Commerce8 5.0 Price Warranty9 6.0 State Sales or Use T

Sales and Distribution Services Agreement, dated November 1, 2017, by and between CPM Medical Consultants, LLC and Max Spine, LLC.

EX-10.46 36 fzmd-ex1046105.htm EX-10.46 EXHIBIT 10.46 CPM MEDICAL CONSULTANTS, LLC SALES AND DISTRIBUTION SERVICES AGREEMENT THIS SALE AND DISTRIBUTION SERVICES AGREEMENT, dated as of November 1st, 2017 (the “Agreement”), is entered into by and between CPM MEDICAL CONSULTANTS, LLC, a Texas Limited Liability Company having its principal place of business at 1565 N. Central Expressway, Suite 200, Ri

Purchase and Sales Agreement, dated March 14, 2018, by and between CPM Medical Consultants, LLC and Texas Overlord, LLC. (filed as Exhibit 10.49 to the Company’s Form 10-K, filed on March 21, 2019 and incorporated herein by reference).

EXHIBIT 10.49 CPM MEDICAL CONSULTANTS, LLC PURCHASE AND SALE AGREEMENT THIS PURCHASE AND SALE AGREEMENT, dated as of March 14, 2018 (the “Agreement”), is entered into by and between CPM Medical Consultants, LLC, a Texas Limited Liability Company having its principal place of business at 1565 N. Central Expressway, Suite 220, Richardson, TX 75080 (“Purchaser”), and Texas Overlord, LLC, having its p

Stocking and Distribution Agreement, dated January 1, 2018, by and between CPM Medical Consultants, LLC and NBMJ, Inc. D/B/A Incare Technologies. (filed as Exhibit 10.52 to the Company’s Form 10-K, filed on March 21, 2019 and incorporated herein by reference).

EXHIBIT 10.52 CPM MEDICAL CONSULTANTS, LLC STOCKING AND SUBDISTRIBUTION AGREEMENT THIS STOCKING AND SUBDISTRIBUTION AGREEMENT, dated as of January 1, 2018 (the “Agreement”), is entered into by and between CPM Medical Consultants, LLC, a Texas Limited Liability Company having its principal place of business at 1565 N. Central Expressway, Suite 200, Richardson, TX 75080 (“Distributor”), and NBMJ, In

Sales and Distribution Services Agreement, dated November 1, 2017, by and between CPM Medical Consultants, LLC and Reeg Medical Industries, Inc. (filed as Exhibit 10.63 to the Company’s Form 10-K, filed on March 21, 2019 and incorporated herein by reference).

EXHIBIT 10.63 CPM MEDICAL CONSULTANTS, LLC SALES AND DISTRIBUTION SERVICES AGREEMENT THIS SALE AND DISTRIBUTION SERVICES AGREEMENT, dated as of November 1st, 2017 (the “Agreement”), is entered into by and between CPM MEDICAL CONSULTANTS, LLC, a Texas Limited Liability Company having its principal place of business at 1565 N. Central Expressway, Suite 200, Richardson, TX 75080 (“Distributor”), and

Stocking and Distribution Agreement, dated November 1, 2017, by and between CPM Medical Consultants, LLC and Palm Springs Partners D/B/A Maxim Surgical, LLC.

EX-10.53 43 fzmd-ex1053119.htm EX-10.53 EXHIBIT 10.53 PALM SPRINGS PARTNERS D/B/A MAXIM SURGICAL, LLC STOCKING AND SUBDISTRIBUTION AGREEMENT THIS STOCKING AND SUBDISTRIBUTION AGREEMENT, dated as of November 1st, 2017 (the “Agreement”), is entered into by and between Palm Springs Partners dba Maxim Surgical, LLC, a Texas Limited Liability Company having its principal place of business at 1565 N. Ce

Distributorship Agreement, dated March 29, 2018, by and between CPM Medical Consultants, LLC and Signature Orthopaedics Pty Ltd.

EX-10.43 33 fzmd-ex104399.htm EX-10.43 EXHIBIT 10.43 Dated 29/3/18 Distributorship agreement between Signature Orthopaedics Pty Ltd And CPM Medical Consultants LLC EXHIBIT 10.43 THIS AGREEMENT is dated Parties (1) Signature Orthopaedics Pty Ltd (ACN 106 702 416) , 7 Sirius Road, Lane Cove, NSW (2) CPM Medical Consultants, LLC of 1565N. Central Expressway, Suite 200, Dallas, TX 75080. Background Th

Distributorship Agreement, dated October 1, 2015, by and between CPM Medical Consultants, LLC and Vivex Biomedical, Inc. (filed as Exhibit 10.26 to the Company’s Form 10-K, filed on March 21, 2019 and incorporated herein by reference).

EXHIBIT 10.26 DISTRIBUTORSHIP AGREEMENT This Distributorship Agreement ("Agreement"), effective the 1st day of October 2015 (the "Effective Date"), is between Vivex Biomedical, I e., a Delaware corporation ("Company") and CPM Medical Consultants, LLC a LimitedLiabilityCompany, specifically including their affiliates and subsidiaries/(“Distributor")(individually "Party" and collectively "Parties").

Amendment Number 1 to Biologics Purchasing Agreement dated January 1, 2018, by and between CPM Medical Consultants, LLC and North Texas Division, Inc., D/B/A Medical City Healthcare.

EX-10.17 7 fzmd-ex101781.htm EX-10.17 EXHIBIT 10.17 Amendment to Purchasing Agreement Agreement Number: NTD-5086 Effective as of January 1, 2018, North Texas Division, Inc., d/b/a Medical City Healthcare having its principal place of business at 6565 North MacArthur Blvd., Suite 350, Irving, TX 75039 (hereinafter referred to as “Division/Facility”), and CPM Medical, (hereinafter referred to as “Se

Distribution Agreement, dated January 1, 2011, by and between CPM Medical Consultants, LLC and United Orthopedic Corporation.

EXHIBIT 10.29 DISTRIBUTION AGREEMENT This Distribution Agreement (the "Agreement') is entered into by and between United Orthopedic Corporation (UOC), with principle business address at No. 57, Park Ave. 2, Science Park, Hsinchu, 300 Taiwan (hereafter '`UOC" or "Company") and CPM Medical Inc. (hereafter "Distributor") having a principle place of business at 3004 Nottingham Drive McKinney, Texas 75

Consulting Agreement, dated March 1, 2018, by and between Fuse Medical, Inc. and Jarrod Rogers.

EX-10.42 32 fzmd-ex1042101.htm EX-10.42 EXHIBIT 10.42 1012 JARM, LLC Jarrod Rogers 3105 Overlook Circle Highland Village, TX 75077 Dear Mr. Rogers, This letter agreement (this “Agreement”) sets forth the terms and conditions whereby you, Jarrod Rogers (“you” or “Consultant”), agree to provide certain services (as described on Schedule I) to Fuse Medical, Inc. (the “Company”). 1.SERVICES. 1.1The Co

Stocking and Distribution Agreement, dated December 1, 2017, by and between CPM Medical Consultants, LLC and Osteo 360, LLC.

EXHIBIT 10.45 CPM MEDICAL CONSULTANTS, LLC STOCKING AND SUBDISTRIBUTION AGREEMENT THIS STOCKING AND SUBDISTRIBUTION AGREEMENT, dated as of December 1st, 2017 (the “Agreement”), is entered into by and between CPM Medical Consultants, LLC, a Texas Limited Liability Company having its principal place of business at 1565 N. Central Expressway, Suite 200, Richardson, TX 75080 (“Distributor”), and Osteo

Commercial Property Lease Agreement dated July 14, 2017 by and between Fuse Medical, Inc. and 1565 North Central Expressway, LP. (filed as Exhibit 10.5 to the Company’s Form 10-K, filed on March 21, 2019 and incorporated herein by reference).

EX-10.5 3 fzmd-ex105125.htm EX-10.5 EXHIBIT 10.5 Commercial Property Lease Agreement This Commercial Property Lease Agreement (“Lease”) is made and effective July 14, 2017, by and between 1565 North Central Expressway, LP (“Landlord”) and Fuse Medical, Inc. (“Tenant”). Landlord is the Owner of land and improvements commonly known and numbered as 1565 North Central Expressway, Suite 220, Richardson

Sales and Distribution Services Agreement, dated November 1, 2017, by and between CPM Medical Consultants, LLC and Texas Overlord, LLC. (filed as Exhibit 10.51 to the Company’s Form 10-K, filed on March 21, 2019 and incorporated herein by reference).

EXHIBIT 10.51 CPM MEDICAL CONSULTANTS, LLC SALES AND DISTRIBUTION SERVICES AGREEMENT THIS SALE AND DISTRIBUTION SERVICES AGREEMENT, dated as of November 1, 2017 (the “Agreement”), is entered into by and between CPM MEDICAL CONSULTANTS, LLC, a Texas Limited Liability Company having its principal place of business at 1565 N. Central Expressway, Suite 200, Richardson, TX 75080 (“Distributor”), and Te

Stocking and Distribution Agreement, dated November 1, 2017, by and between CPM Medical Consultants, LLC and Bass Bone & Spine Specialists, LLC. (filed as Exhibit 10.56 to the Company’s Form 10-K, filed on March 21, 2019 and incorporated herein by reference).

EXHIBIT 10.56 CPM MEDICAL CONSULTANTS, LLC STOCKING AND SUBDISTRIBUTION AGREEMENT THIS STOCKING AND SUBDISTRIBUTION AGREEMENT, dated as of November 1st, 2017 (the “Agreement”), is entered into by and between CPM Medical Consultants, LLC, a Texas Limited Liability Company having its principal place of business at 1565 N. Central Expressway, Suite 200, Richardson, TX 75080 (“Distributor”), and BASS

Stocking and Distribution Agreement, dated November 1, 2017, by and between CPM Medical Consultants, LLC and Tiger Orthopedics, LLC. (filed as Exhibit 10.57 to the Company’s Form 10-K, filed on March 21, 2019 and incorporated herein by reference).

EXHIBIT 10.57 CPM MEDICAL CONSULTANTS, LLC STOCKING AND SUBDISTRIBUTION AGREEMENT THIS STOCKING AND SUBDISTRIBUTION AGREEMENT, dated as of November 1st, 2017 (the “Agreement”), is entered into by and between CPM Medical Consultants, LLC, a Texas Limited Liability Company having its principal place of business at 1565 N. Central Expressway, Suite 200, Richardson, TX 75080 (“Distributor”), and Tiger

Stocking and Distribution Agreement, dated January 1, 2018, by and between CPM Medical Consultants, LLC and Epic Orthopedic Management, LLC.

EXHIBIT 10.60 CPM MEDICAL CONSULTANTS, LLC STOCKING AND SUBDISTRIBUTION AGREEMENT THIS STOCKING AND SUBDISTRIBUTION AGREEMENT, dated as of January 1, 2018 (the “Agreement”), is entered into by and between CPM Medical Consultants, LLC, a Texas Limited Liability Company having its principal place of business at 1565 N. Central Expressway, Suite 200, Richardson, TX 75080 (“Distributor”), and Epic Ort

Sales and Distribution Services Agreement, dated November 1, 2017, by and between CPM Medical Consultants, LLC and Texas Overlord, LLC. (filed as Exhibit 10.50 to the Company’s Form 10-K, filed on March 21, 2019 and incorporated herein by reference).

EX-10.50 40 fzmd-ex1050122.htm EX-10.50 EXHIBIT 10.50 CPM MEDICAL CONSULTANTS, LLC SALES AND DISTRIBUTION SERVICES AGREEMENT THIS SALE AND DISTRIBUTION SERVICES AGREEMENT, dated as of November 1, 2017 (the “Agreement”), is entered into by and between CPM MEDICAL CONSULTANTS, LLC, a Texas Limited Liability Company having its principal place of business at 1565 N. Central Expressway, Suite 200, Rich

Sales and Distribution Services Agreement, dated November 1, 2017, by and between CPM Medical Consultants, LLC and Neurospine Consultants, LLC.

EXHIBIT 10.47 CPM MEDICAL CONSULTANTS, LLC SALES AND DISTRIBUTION SERVICES AGREEMENT THIS SALE AND DISTRIBUTION SERVICES AGREEMENT, dated as of November 1st, 2017 (the “Agreement”), is entered into by and between CPM MEDICAL CONSULTANTS, LLC, a Texas Limited Liability Company having its principal place of business at 1565 N. Central Expressway, Suite 200, Richardson, TX 75080 (“Distributor”), and

Purchase Agreement, dated February 1, 2018, by and between CPM Medical Consultants, LLC and Methodist Hospitals of Dallas D/B/A Methodist Health System.

EXHIBIT 10.44 MASTER IMPLANT PURCHASE AGREEMENT BY AND BETWEEN METHODIST HEALTH SYSTEM AND CPM Medical Consultants, LLC WHEREAS, this Master Implant Purchase Agreement is made effective as of the 1 day of February, 2018 (the “Effective Date”) by and between Methodist Hospitals of Dallas d/b/a Methodist Health System (“MHS” or “Customer”), a Texas nonprofit corporation whose address is 1441 N. Beck

Amendment Number 1 to Distribution Agreement, dated January 5, 2011, by and between CPM Medical Consultants, LLC and Arteriocyte Medical Systems, Inc.

EX-10.36 26 fzmd-ex103688.htm EX-10.36 EXHIBIT 10.36 Amendment to the Distribution Agreement This Amendment to the Distribution Agreement ("the Amendment") entered into on January 5, 2011 by and between Arteriocyte Medical Systems, Inc. (the "Company"), a Delaware Corporation and CPM Medical (the 'Distributor") (collectively, "the Parties"), a Delaware Corporation, modifies the Distribution Agreem

Amendment Number 1 to Distributor Agreement, dated April 1, 2013, by and between CPM Medical Consultants, LLC and UOC USA, Inc.

EX-10.30 20 fzmd-ex103093.htm EX-10.30 EXHIBIT 10.30 UOC USA Inc. 20 Fairbanks, Suite 173, Irvine, CA 92618 Tel 949.328.3356 / Fax : 949.328.3367 www.uocusa.com AMENDMENT TO DISTRIBUTOR AGREEMENT This AMENDEMENT TO DISTRIBUTOR AGREEMENT (this "Agreement") is made this first day of April, 2013 (the "Effective Date") by and between UOCUSA INC., a California corporation("UOC"),having its principal of

Amendment to Number 1 to Spinal Implants Purchasing Agreement, dated January 1, 2018, by and between CPM Medical Consultants, LLC and El Paso Healthcare System, LTD.

EXHIBIT 10.19 Amendment to Purchasing Agreement Agreement Number: 24177 Effective as of January 1, 2018, EL PASO HEALTHCARE SYSTEM, LTD., having its principal place of business at 4100 Rio Bravo, El Paso, TX 79902 (hereinafter referred to as "Division/Facility"), and CPM Medical Consultants, LLC, (hereinafter referred to as "Seller" or "Vendor"), having its principal place of business at 1565 N. C

Spinal Implants Purchasing Agreement, dated April 1, 2016, by and between CPM Medical Consultants, LLC and North Texas Division, Inc., D/B/A Medical City Healthcare.

EXHIBIT 10.14 PURCHASING AGREEMENT Products Division:North Texas Division, Inc. Vendor:CPM Medical Products:SPINAL IMPLANTS Effective Date:April 1, 2016 Agreement Number: Draft Date: Table of Contents Page 1.0 Definitions1 2.0 General Purchasing Provisions4 3.0 Rebates, Reporting, Prices, Payments7 4.0 EDI and E-Commerce8 5.0 Price Warranty9 6.0 Taxes10 7.0 Vendor Delivery Performance; Cancellatio

Amendment Number 1 to Spinal Implants Purchasing Agreement dated May 1, 2018, by and between CPM Medical Consultants, LLC and North Texas Division, Inc., D/B/A Medical City Healthcare.

EXHIBIT 10.15 Amendment to Purchasing Agreement Agreement Number: NTD-7740 Effective as of May 1, 2018, North Texas Division, Inc., d/b/a Medical City Healthcare having its principal place of business at 6565 North MacArthur Blvd., Suite 350, Irving, TX 75039 (hereinafter referred to as “Division/Facility”), and CPM Medical Consultants, LLC, (hereinafter referred to as “Seller” or “Vendor”), havin

Spinal Implants Purchasing Agreement, dated April 1, 2017, by and between CPM Medical Consultants, LLC and El Paso Healthcare System, LTD.

EXHIBIT 10.18 PURCHASING AGREEMENT Products Division:El Paso Healthcare System, LTD. Vendor:CPM Medical Consultants, LLC Products:SPINAL IMPLANTS Effective Date:April 1, 2017 Agreement Number: Draft Date: Table of Contents Page 1.0 Definitions1 2.0 General Purchasing Provisions4 3.0 Rebates, Reporting, Prices, Payments7 4.0 EDI and E-Commerce8 5.0 Price Warranty9 6.0 Taxes10 7.0 Vendor Delivery Pe

Stocking and Distribution Agreement, dated November 1, 2017, by and between CPM Medical Consultants, LLC and Recon Orthopedics, LLC. (filed as Exhibit 10.59 to the Company’s Form 10-K, filed on March 21, 2019 and incorporated herein by reference).

EXHIBIT 10.59 CPM MEDICAL CONSULTANTS, LLC STOCKING AND SUBDISTRIBUTION AGREEMENT THIS STOCKING AND SUBDISTRIBUTION AGREEMENT, dated as of November 1st, 2017 (the “Agreement”), is entered into by and between CPM Medical Consultants, LLC, a Texas Limited Liability Company having its principal place of business at 1565 N. Central Expressway, Suite 200, Richardson, TX 75080 (“Distributor”), and Recon

Lease Agreement, dated August 1, 2013, by and between CPM Medical Consultants, LLC and Palm Springs Partners D/B/A Maxim Surgical, LLC.

EXHIBIT 10.55 Lease Agreement 1.Names. This lease is made by CPM Medical Consultants, LLC, Landlord, and Palm Springs Partners, LLC DBA Maxim Surgical, Tenant. 2. Premises Being Leased. Landlord is leasing to Tenant and Tenant is leasing from Landlord 200 square feet located at the following premises: 1565 N. Central Expressway, Suite 290-A, Richardson, TX 75080 This lease includes access to all p

Indemnification Agreement, dated July 13, 2017, by and between Fuse Medical, Inc. and “Ricky” Raj S. Kalra, M.D. (filed as Exhibit 10.41 to the Company’s Form 10-K, filed on March 21, 2019 and incorporated herein by reference).

EX-10.41 31 fzmd-ex1041102.htm EX-10.41 EXHIBIT 10.41 INDEMNIFICATION AGREEMENT THIS INDEMNIFICATION AGREEMENT (this “Agreement”) is made and entered into as of July 13, 2017, by and between Fuse Medical, Inc., a Delaware corporation (the “Company”), and “Ricky” Raj S. Kalra, M.D. (“Indemnitee”). WHEREAS, Indemnitee is being appointed to serve as a director on the Board of Directors of the Company

Indemnification Agreement, dated August 1, 2017, by and between Fuse Medical, Inc. and Renato V. Bosita Jr., M.D. (filed as Exhibit 10.40 to the Company’s Form 10-K, filed on March 21, 2019 and incorporated herein by reference).

EX-10.40 30 fzmd-ex1040104.htm EX-10.40 EXHIBIT 10.40 INDEMNIFICATION AGREEMENT THIS INDEMNIFICATION AGREEMENT (this “Agreement”) is made and entered into as of August 1, 2017, by and between Fuse Medical, Inc., a Delaware corporation (the “Company”), and Renato V. Bosita Jr., M.D. (“Indemnitee”). WHEREAS, Indemnitee is being appointed to serve as a director on the Board of Directors of the Compan

Indemnification Agreement, dated December 19, 2016, by and between Fuse Medical, Inc. and William E. McLaughlin. (filed as Exhibit 10.39 to the Company’s Form 10-K, filed on March 21, 2019 and incorporated herein by reference).

EXHIBIT 10.39 INDEMNIFICATION AGREEMENT THIS INDEMNIFICATION AGREEMENT (this “Agreement”) is made and entered into as of December 19, 2016, by and between Fuse Medical, Inc., a Delaware corporation (the “Company”), and William E. McLaughlin (“Indemnitee”). WHEREAS, Indemnitee is being appointed to serve as a director on the Board of Directors of the Company (the “Board”), and the Company must ente

Annual Report on Form 10-K for the fiscal year ended December 31, 2018 (filed March 21, 2019 and incorporated herein by reference).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2018 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from to Commission File Number: 000-10093 Fuse Medical, Inc. (Exact

Biologics Purchasing Agreement, dated December 1, 2018, by and between CPM Medical Consultants, LLC and El Paso Healthcare System. LTD.

EXHIBIT 10.20 PURCHASING AGREEMENT Products Division:El Paso Healthcare System, LTD Vendor:CPM Medical Consultants, LLC Products:BIOLOGICS Effective Date:December 1, 2018 Agreement Number: Draft Date: PURCHASING AGREEMENT This Purchasing Agreement is entered into by El Paso Healthcare System, LTD., having its principal place of business at 4100 Rio Bravo, El Paso, TX 79902, as the disclosed agent

Spinal Fusion Purchasing Agreement, dated June 26, 2012, by and between CPM Medical Consultants, LLC and Texas Health Resources.

EXHIBIT 10.21 Spinal Fusion Purchase Agreement Texas Health Resources and CPM Medical Consultants, LLC This Agreement is executed by and between CPM Medical Consultants, LLC, ("Vendor") a Texas Corporation with address at 1585 N. Central Expressway #200, Richardson, Texas 75080 and Texas Health Resources, a Texas non-profit Corporation with address at 612 East Lamar Boulevard, Arlington, Texas 760

Distribution Agreement, dated May 13, 2010, by and between CPM Medical Consultants, LLC and Arteriocyte Medical Systems, Inc.

EXHIBIT 10.35 ARTERICICYTE MEDICAL SYSTEMS Title: Distribution Agreement Stocking — CPM Medical NO. 20100225.7 This Distribution Agreement is entered into on May 13, 2010 by Arteriocyte Medical Systems, Inc. (the "Company" or "AMS"), A Delaware Corporation, located at 11000 Cedar Avenue, Suite 270, Cleveland, OH 44106 and CPM Medical, a Texas Corporation ("Distributor"), located at 3004 Nottingham

Consignment Agreement, dated May 31, 2013, by and between CPM Medical Consultants, LLC and Renovis Surgical Technologies.

EXHIBIT 10.38 CONSIGNMENT AGREEMENT This Agreement (the "Agreement") is made and entered into as of May 31, 2013 by and between Renovis Surgical Technologies, a California Corporation ("Manufacturer"), and CPM Medical Consultants, LLC. ("Distributor") (collectively the "Parties"). RECITALS A.Manufacturer is in the business of designing, manufacturing and distributing products and instruments for t

Amendment Number 1 to Spinal Fusion Purchasing Agreement, dated August 7, 2015, by and between CPM Medical Consultants, LLC and Texas Health Resources.

EXHIBIT 10.22 Addendum to the Spinal Fusion Purchase Agreement between Texas Health Resources and CPM Medical August 7, 2015 The Agreement to which this Addendum is attached and incorporated and is executed by and between CPM Medical ("Vendor"), and Texas Health Resources with its principal place of business at 612 East Lamar Blvd., Suite 1100, Arlington, Texas 76011 ("Customer"), dated as of the

Distributor Agreement, dated January 1, 2016, by and between CPM Medical Consultants, LLC and FH Ortho, Inc. (filed as Exhibit 10.28 to the Company’s Form 10-K, filed on March 21, 2019 and incorporated herein by reference).

EXHIBIT 10.28 FH Ortho Distributor Agreement DISTRIBUTOR AGREEMENT This Agreement is entered into to be effective as of January 1st, 2016 by and between FH Ortho, Inc., 4118 N. Nashville Avenue, Chicago, IL 60634 (the "Company") and CPM Medical Consultants, LLC, 1565 N. Central Expressway, Suite 200, Richardson, TX 75080 ("Distributor"). RECITALS: A.The Company and Distributor desire to establish

Distribution Agreement, dated 2016, by and between CPM Medical Consultants, LLC and Ortho Solutions, Inc.

EXHIBIT 10.31 EXCLUSIVE DISTRIBUTION AGREEMENT Inventory Purchased THIS EXCLUSIVE DISTRIBUTION AGREEMENT (the "Agreement") is dated as of , 2016 and is between Ortho Solutions, Inc. having its principal office located at 330 Franklin Tpke, Mahwah, NJ 07430 ("Ortho"), and CPM Medical Consultants, LLC having its principal office located at 1565 N. Central Express Way, Suite 200, Richardson, TX 75080

Stocking and Distribution Agreement, dated August 31, 2018, by and between CPM Medical Consultants, LLC and Modal Manufacturing, LLC. (filed as Exhibit 10.64 to the Company’s Form 10-K, filed on March 21, 2019 and incorporated herein by reference).

EX-10.64 54 fzmd-ex1064109.htm EX-10.64 EXHIBIT 10.64 AGREEMENT This Agreement (“Agreement”) is made on August 31, 2018 by and between Modal Manufacturing, LLC (“Modal”), a Florida limited liability company, with its principal place of business at 10190 Riverside Drive, Suite 103, Palm Beach Gardens, FL 33410 and CPM Medical Consultants, LLC a Texas limited liability company (“Stocking Distributor

FUSE MEDICAL, INC. OTC Markets Lists Securities of Fuse Medical, Inc. as Exempt from Penny Stock Designation

EX-99.1 Exhibit 99.1 For Immediate Release Contact: Fuse Medical, Inc. Attention: Devon Morgan, Investor Relations Analyst 1565 North Central Expressway, Suite 220 Richardson, Texas 75080 Office (469) 862-3030 Facsimile (469) 862-3035 [email protected] FUSE MEDICAL, INC. OTC Markets Lists Securities of Fuse Medical, Inc. as Exempt from Penny Stock Designation RICHARDSON, TX, March 14, 2019 /Bus

Financial Statements and Exhibits, Other Events

8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 14, 2019 (March 14, 2019) FUSE MEDICAL, INC. (Exact name of Registrant as specified in its charter) Delaware 000-10093 59-1224913 (State or other jurisdiction of incorporati

Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders

8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 11, 2019 (February 9, 2019) FUSE MEDICAL, INC. (Exact name of Registrant as specified in its charter) Delaware 000-10093 59-1224913 (State or other jurisdiction of incorp

Power of Attorney (see signature page)

S-8 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 FUSE MEDICAL, INC. (Exact name of Registrant as specified in its charter) Delaware 59-1224913 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) 1565 N. Central Expressway, Suite 220 Richardson, TX 75080 (Addre

FZMD / Fuse Medical, Inc. DEFA14C

DEFA14C UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: ☐ Preliminary Information Statement ☐ Confidential, for use of the Commission only (as permitted by Rule 14c-5(d)(2)) ☐ Definitive information statement ☒ Definitive additional mate

FZMD / Fuse Medical, Inc. DEF 14C

DEF 14C Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.

AMENDED AND RESTATED 2018 EQUITY INCENTIVE PLAN OF FUSE MEDICAL, INC. RESTRICTED STOCK AWARD NOTICE

EX-99.1 Exhibit 99.1 AMENDED AND RESTATED 2018 EQUITY INCENTIVE PLAN OF FUSE MEDICAL, INC. RESTRICTED STOCK AWARD NOTICE Fuse Medical, Inc. (the “Company”) hereby grants to you a Restricted Stock Award (the “Award”) for shares of the Company’s Common Stock under the Company’s Amended and Restated 2018 Equity Incentive Plan of Fuse Medical, Inc. (the “Plan”). The Award is subject to all the terms a

AMENDED AND RESTATED 2018 EQUITY INCENTIVE PLAN OF FUSE MEDICAL, INC. STOCK OPTION GRANT NOTICE

EX-99.2 Exhibit 99.2 AMENDED AND RESTATED 2018 EQUITY INCENTIVE PLAN OF FUSE MEDICAL, INC. STOCK OPTION GRANT NOTICE Fuse Medical, Inc. (the “Company”) hereby grants to you an Option (the “Option”) to purchase shares of the Company’s Common Stock under the Company’s Amended and Restated 2018 Equity Incentive Plan of Fuse Medical, Inc. (the “Plan”). The Option is subject to all the terms and condit

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Entry into a Material Definitive Agreement, Financial Statements and Exhibits

8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 18, 2018 (December 13, 2018) FUSE MEDICAL, INC. (Exact name of Registrant as specified in its charter) Delaware 000-10093 59-1224913 (State or other jurisdiction of incor

Amended and Restated 2018 Equity Incentive Plan of Fuse Medical, Inc. (filed as Exhibit 10.1 to our Company’s Form 8-K filed December 18, 2018 and incorporated herein by reference).

EX-10.1 Exhibit 10.1 AMENDED AND RESTATED 2018 EQUITY INCENTIVE PLAN OF FUSE MEDICAL, INC. 1. Purpose; Eligibility. 1.1 General Purpose. The name of this plan is the Amended and Restated 2018 Equity Incentive Plan of Fuse Medical, Inc. (the “Plan”) The purposes of the Plan are to (a) enable Fuse Medical, Inc. (the “Company”), and any Affiliate to attract and retain the types of Employees, Consulta

Fuse Medical, Inc. Ranked No. 56 Fastest Growing Company in North America on Deloitte’s 2018 Technology Fast 500TM

EX-99.1 Exhibit 99.1 For Immediate Release Contact: Fuse Medical, Inc. Attention: Devon Peddie, Investor Relations Analyst 1565 North Central Expressway, Suite 220 Richardson, Texas 75080 Office (469) 862-3030 Facsimile (469) 862-3035 [email protected] Fuse Medical, Inc. Ranked No. 56 Fastest Growing Company in North America on Deloitte’s 2018 Technology Fast 500TM RICHARDSON, TX, November 20,

Regulation FD Disclosure, Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 21, 2018 (November 19, 2018) FUSE MEDICAL, INC. (Exact name of Registrant as specified in its charter) Delaware 000-10093 59-1224913 (State or other jurisdiction of

Limited Waiver and Second Amendment to Amended and Restated Business Loan Agreement, dated November 19, 2018, by and among ZB, N.A. (D/B/A Amegy Bank), Fuse Medical, Inc., and CPM Medical Consultants, LLC (filed as Exhibit 10.3 to our company’s Form 8-K filed on November 21, 2018 and incorporated herein by reference).

EX-10.3 Exhibit 10.3 Execution Version LIMITED WAIVER AND SECOND AMENDMENT TO AMENDED AND RESTATED BUSINESS LOAN AGREEMENT This LIMITED WAIVER AND SECOND AMENDMENT TO AMENDED AND RESTATED BUSINESS LOAN AGREEMENT (this “Amendment”), dated as November 19, 2018 (“Second Amendment Effective Date”), is made and entered into by and among Zions Bancorporation, N.A. dba Amegy Bank (together with its succe

Limited Waiver and First Amendment to Amended and Restated Business Loan Agreement, dated September 21, 2018, by and among ZB, N.A. (D/B/A Amegy Bank), Fuse Medical, Inc., and CPM Medical Consultants, LLC (filed as Exhibit 10.2 to our Company’s Form 8-K filed on November 21, 2018 and incorporated herein by reference).

EX-10.2 Exhibit 10.2 Execution Version LIMITED WAIVER AND FIRST AMENDMENT TO AMENDED AND RESTATED BUSINESS LOAN AGREEMENT This LIMITED WAIVER AND FIRST AMENDMENT TO AMENDED AND RESTATED BUSINESS LOAN AGREEMENT (this “Amendment”), dated as of September 21, 2018 (“First Amendment Effective Date”), is made and entered into by and among ZB, N.A. (d/b/a Amegy Bank) (together with its successors and ass

Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets

8-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A (Amendment No. 2) CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 16, 2018 (July 30, 2018) FUSE MEDICAL, INC. (Exact name of Registrant as specified in its charter) Delaware 000-10093 59-1224913 (State or other jur

FZMD / Fuse Medical, Inc. 10-Q (Quarterly Report)

10-Q 1 fzmd-10q20180930.htm 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: September 30, 2018 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 000-10093 Fuse Medical, Inc.

FUSE MEDICAL, INC. AND PALM SPRINGS PARTNERS, LLC d/b/a MAXIM SURGICAL

Exhibit 99.3 FUSE MEDICAL, INC. UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL STATEMENTS On August 1, 2018, Fuse Medical, Inc. (the “Company”) completed the previously-announced acquisition of Palm Springs Partners LLC d/b/a Maxim Surgical (“Maxim”), a Texas limited liability company, pursuant to that certain Purchase Agreement, by and between the Company, Maxim, Reeg Medical Industries, Inc.,

Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 12, 2018 (July 30, 2018) FUSE MEDICAL, INC. (Exact name of Registrant as specified in its charter) Delaware 000-10093 59-1224913 (State or other jurisdicti

Table of Contents

Exhibit 99.2 Palm Springs Partners, LLC d/b/a Maxim Surgical Interim Financial Statements (Unaudited) June 30, 2018 Table of Contents Interim financial statements (unaudited) Balance sheets as of June 30, 2018 and December 31, 2017 2 Statements of operations for the six months ended June 30, 2018 and 2017 3 Statements of cash flows for the six months ended June 30, 2018 and 2017 4 Notes to financi

Table of Contents

Exhibit 99.1 Palm Springs Partners, LLC d/b/a Maxim Surgical Financial Statements December 31, 2017 and 2016 Table of Contents Independent auditors report 1 Financial statements Balance sheets 2 Statements of operations 3 Statements of changes in members’ equity 4 Statements of cash flows 5 Notes to financial statements 6-11 Montgomery Coscia Greilich LLP 972-748-0300 p 972-748-0700 f INDEPENDENT

Amendment Number 1 to Annual Report on Form 10-K/A for the fiscal year ended December 31, 2017 (filed September 21, 2018 and incorporated herein by reference).

10-K/A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.

FZMD / Fuse Medical, Inc. CORRESP

CORRESP Table of Contents August 24, 2018 By Overnight Delivery, Email & EDGAR Filed United States Securities and Exchange Commission 100 F.

FZMD / Fuse Medical, Inc. CORRESP

CORRESP Table of Contents August 24, 2018 By Overnight Delivery, Email & EDGAR Filed United States Securities and Exchange Commission 100 F.

FZMD / Fuse Medical, Inc. 10-Q (Quarterly Report)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: June 30, 2018 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 000-10093 Fuse Medical, Inc. (Exact name of registrant as specified

FZMD / Fuse Medical, Inc. NT 10-Q

NT 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC File Number: 000-10093 CUSIP Number: 36113U101 (Check One): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For period ended: June 30, 2018 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K

FZMD / Fuse Medical, Inc. / Brooks Mark W - SC 13D/A Activist Investment

SC 13D/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A (Amendment No. 1) FUSE MEDICAL, INC. (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 36113U101 (CUSIP Number) Mark W. Brooks NC 143 Family Holdings, LP 1565 North Central Expressway, Suite 200 Richardson, Texas 75080 Telephone No.: (214) 289-9914 (Name, Address and Telephone Nu

FZMD / Fuse Medical, Inc. / Reeg Christopher C - SC 13D/A Activist Investment

SC 13D/A 1 d593098dsc13da.htm SC 13D/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A (Amendment No. 1) FUSE MEDICAL, INC. (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 36113U101 (CUSIP Number) Christopher C. Reeg Reeg Medical Industries, Inc. 3024 Westminster Ave. Dallas, Texas 75205 Telephone No.: (214) 564-1350 (Name, Address a

FAIRNESS OPINION RELATED TO THE ACQUISITION OF PALM SPRINGS PARTNERS, LLC D/B/A MAXIM SURGICAL BY FUSE MEDICAL, INC. JULY 25, 2018 Prepared for: Board of Directors Fuse Medical, Inc.

EX-99.1 Exhibit 99.1 FAIRNESS OPINION RELATED TO THE ACQUISITION OF PALM SPRINGS PARTNERS, LLC D/B/A MAXIM SURGICAL BY FUSE MEDICAL, INC. JULY 25, 2018 Prepared for: Board of Directors Fuse Medical, Inc. July 25, 2018 Board of Directors Fuse Medical, Inc. 1565 North Central Expressway Suite 220 Richardson, TX 75080 Dear Members of the Board: ValueScope, Inc. has been engaged to advise Fuse Medical

FUSE MEDICAL, INC. Fuse Medical, Inc. Completes Acquisition of Maxim Surgical

EX-99.2 4 d599187dex992.htm EX-99.2 Exhibit 99.2 For Immediate Release Contact: Fuse Medical, Inc. Attention: Devon Peddie, Investor Relations Analyst 1565 North Central Expressway, Suite 220 Richardson, Texas 75080 Office (469) 862-3030 Facsimile (469) 862-3035 [email protected] FUSE MEDICAL, INC. Fuse Medical, Inc. Completes Acquisition of Maxim Surgical RICHARDSON, TX, August 2, 2018 /Busine

Securities Purchase Agreement, dated July 30, 2018, by and among Fuse Medical, Inc.; Palm Springs Partners, LLC d/b/a Maxim Surgical, a Texas limited liability company; Reeg Medical Industries, Inc., a Texas corporation, and Amir David Tahernia, an individual, as Sellers; and Mr. Amir David Tahernia in his capacity as representative of the Sellers (filed as Exhibit 2.1 to the Company’s Form 8-K filed August 3, 2018, and incorporated herein by reference).

Exhibit 2.1 SECURITIES PURCHASE AGREEMENT DATED AS OF JULY 30, 2018 By and Among Fuse Medical, Inc., Palm Springs Partners, LLC d/b/a Maxim Surgical, Mr. Amir David Tahernia, Reeg Medical Industries, Inc., and Mr. Amir David Tahernia, in his capacity as Sellers’ Representative ARTICLE 1 PURCHASE AND SALE OF ACQUIRED SECURITIES; CLOSING 1 1.1 Purchase and Sale of Acquired Securities 1 1.2 Purchase

Regulation FD Disclosure, Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets

8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 3, 2018 (July 30, 2018) FUSE MEDICAL, INC. (Exact name of Registrant as specified in its charter) Delaware 000-10093 59-1224913 (State or other jurisdiction of incorporatio

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 5, 2018 (June 28, 2018) FUSE MEDICAL, INC. (Exact name of Registrant as specified in its charter) Delaware 000-10093 59-1224913 (State or other jurisdiction of incorporation

Amendment Number 4 to the 2017 Equity Incentive Plan of Fuse Medical, Inc. dated July 5, 2018 (filed as Exhibit 10.1 to our Company’s Form 8-K filed July 5, 2018 and incorporated herein by reference).

EX-10.1 Exhibit 10.1 2017 EQUITY INCENTIVE PLAN OF FUSE MEDICAL, INC. AMENDMENT NO. 4 June 28, 2018 Section 4.1. Section 4.1 of the 2017 Equity Incentive Plan of Fuse Medical, Inc., dated April 5, 2017, is removed in its entirety and replaced by the following: 4.1 Subject to adjustment in accordance with Section 11, a total of 8,000,000 shares of Common Stock shall be available for the grant of Aw

FZMD / Fuse Medical, Inc. CORRESP

CORRESP June 6, 2018 By Overnight Delivery, Email & EDGAR Filed United States Securities and Exchange Commission 100 F.

FZMD / Fuse Medical, Inc. 10-Q (Quarterly Report)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: March 31, 2018 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 000-10093 Fuse Medical, Inc. (Exact name of registrant as specifie

FZMD / Fuse Medical, Inc. CORRESP

CORRESP May 10, 2018 By Overnight Delivery United States Securities and Exchange Commission 100 F.

Form Commission Agreement, dated as of March 1, 2018, by and between CPM Medical Consultants, LLC and Max Spine, LLC. (Filed as Exhibit 10.12 to the Company’s original Form 10-K, filed on April 6, 2018, and incorporated herein by reference).

Exhibit 10.12 CPM MEDICAL CONSULTANTS, LLC SALES AND DISTRIBUTION SERVICES AGREEMENT THIS SALE AND DISTRIBUTION SERVICES AGREEMENT, dated as of March 1st, 2018 (the “Agreement”), is entered into by and between CPM MEDICAL CONSULTANTS, LLC, a Texas Limited Liability Company having its principal place of business at 1565 N. Central Expressway, Suite 200, Richardson, TX 75080 (“Distributor”), and ,a

Commercial Property Lease Agreement dated January 1, 2013 by and between CPM Medical Consultants, LLC and 1565 North Central Expressway, LP.

Exhibit 10.14 Net Lease for Entire Building 1. Names. This lease is made by 1565 N. Central Expressway, LP, Landlord, and CPM Medical Consultants, LLC, Tenant. 2.Premises Being Leased. Landlord is leasing to Tenant and Tenant is leasing from Landlord the following premises: 1565 N. Central Expressway, 2nd Floor, Richardson, TX 75080 3. Term of Lease. This lease begins on January 1, 2013, and ends

Form Stocking Distribution Agreement, dated as of November 1, 2017, by and between CPM Medical Consultants, LLC and MedUSA Group, LLC.

Exhibit 10.4 CPM MEDICAL CONSULTANTS, LLC STOCKING AND SUBDISTRIBUTION AGREEMENT THIS STOCKING AND SUBDISTRIBUTION AGREEMENT, dated as of [, 20] (the “Agreement”), is entered into by and between CPM Medical Consultants, LLC, a Texas Limited Liability Company having its principal place of business at 1565 N. Central Expressway, Suite 200, Richardson, TX 75080 (“Distributor”), and [], a [] corporati

Form Stocking Distribution Agreement, dated as of November 1, 2017, by and between CPM Medical Consultants, LLC and Sintu, LLC.

Exhibit 10.8 CPM MEDICAL CONSULTANTS, LLC STOCKING AND SUBDISTRIBUTION AGREEMENT THIS STOCKING AND SUBDISTRIBUTION AGREEMENT, dated as of [, 20] (the “Agreement”), is entered into by and between CPM Medical Consultants, LLC, a Texas Limited Liability Company having its principal place of business at 1565 N. Central Expressway, Suite 200, Richardson, TX 75080 (“Distributor”), and [], a [] corporati

Form Commission Agreement, dated as of March 1, 2018, by and between CPM Medical Consultants, LLC and 1012 Jarm, LLC. (Filed as Exhibit 10.11 to the Company’s original Form 10-K, filed on April 6, 2018, and incorporated herein by reference).

Exhibit 10.11 CPM MEDICAL CONSULTANTS, LLC SALES AND DISTRIBUTION SERVICES AGREEMENT THIS SALE AND DISTRIBUTION SERVICES AGREEMENT, dated as of March 1st, 2018 (the “Agreement”), is entered into by and between CPM MEDICAL CONSULTANTS, LLC, a Texas Limited Liability Company having its principal place of business at 1565 N. Central Expressway, Suite 200, Richardson, TX 75080 (“Distributor”), and ,a

List of Subsidiaries of Fuse Medical, Inc.

Exhibit 21.1 Fuse Medical, Inc. (A Delaware Corporation) List of Significant Subsidiaries (As of December 31, 2017) CPM Medical Consultants, LLC

Form Stocking Distribution Agreement, dated as of November 1, 2017, by and between CPM Medical Consultants, LLC and N.B.M.J. Inc.

Exhibit 10.6 CPM MEDICAL CONSULTANTS, LLC STOCKING AND SUBDISTRIBUTION AGREEMENT THIS STOCKING AND SUBDISTRIBUTION AGREEMENT, dated as of [, 20] (the “Agreement”), is entered into by and between CPM Medical Consultants, LLC, a Texas Limited Liability Company having its principal place of business at 1565 N. Central Expressway, Suite 200, Richardson, TX 75080 (“Distributor”), and [], a [] corporati

Form Stocking Distribution Agreement, dated as of November 1, 2017, by and between Maxim Surgical, LLC and CPM Medical Consultants, LLC.

Exhibit 10.9 CPM MEDICAL CONSULTANTS, LLC STOCKING AND SUBDISTRIBUTION AGREEMENT THIS STOCKING AND SUBDISTRIBUTION AGREEMENT, dated as of [, 20] (the “Agreement”), is entered into by and between CPM Medical Consultants, LLC, a Texas Limited Liability Company having its principal place of business at 1565 N. Central Expressway, Suite 200, Richardson, TX 75080 (“Distributor”), and [], a [] corporati

Form Commission Agreement, dated as of March 1, 2018, by and between CPM Medical Consultants, LLC and Neurospine Consultants, LLC. (Filed as Exhibit 10.10 to the Company’s original Form 10-K, filed on April 6, 2018, and incorporated herein by reference).

Exhibit 10.10 CPM MEDICAL CONSULTANTS, LLC SALES AND DISTRIBUTION SERVICES AGREEMENT THIS SALE AND DISTRIBUTION SERVICES AGREEMENT, dated as of March 1st, 2018 (the “Agreement”), is entered into by and between CPM MEDICAL CONSULTANTS, LLC, a Texas Limited Liability Company having its principal place of business at 1565 N. Central Expressway, Suite 200, Richardson, TX 75080 (“Distributor”), and ,a

Specimen Stock Certificate (filed as Exhibit 4.1 to the Company’s Form 10-K, filed on April 6, 2018 and incorporated herein by reference).

N U M B E R S H A R E S COMMON STOCK PAR VALUE $.01 COMMON STOCK PAR VALUE $.01 CUSIP 36113U 10 1 FUSE MEDICAL, INC. (INCORPORATED UNDER THE LAWS OF DELAWARE) SEE REVERSE FOR CERTAIN DEFINITIONS This certifies that is the owner of FULLY PAID AND NON-ASSESSABLE SHARES OF THE PAR VALUE $.01 EACH, OF THE COMMON STOCK OF FUSE MEDICAL, INC. transferable on the books of the Corporation by the holder her

Annual Report on Form 10-K for the fiscal year ended December 31, 2017 (filed April 6, 2017 and incorporated herein by reference).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2017 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from to Commission File Number: 000-10093 FUSE MEDICAL, INC. (Exact

Private Label Supply Agreement, dated November 1, 2016, by and between Tyber Medical, LLC and CPM Medical Consultants, LLC (filed as Exhibit 10.13 to the Company’s Form 10-K, filed on April 6, 2018 and incorporated herein by reference).

Exhibit 10.13 PRIVATE LABEL SUPPLY AGREEMENT THIS PRIVATE LABEL SUPPLY AGREEMENT (“Agreement”) is entered as of November 1, 2016 (the “Effective Date”), by and between Tyber Medical, LLC, a New Jersey limited liability company (“Supplier”) and CPM Medical Consultants, LLC, a Texas Liability Corporation (“Distributor”). R E C I T A L S WHEREAS, Supplier is engaged in the business of developing inno

Professional Employer Organization Client Service Agreement, dated January 1, 2015 by and between CPM Medical Consultants, LLC and AmBio Staffing, LLC (filed as Exhibit 10.19 to the Company’s Form 10-K, filed on April 6, 2018 and incorporated herein by reference).

Exhibit 10.19 Professional Employer Organization Client Service Agreement This Professional Employer Organization ("PEO") Client Service Agreement (the " Agreement" ), dated as of January 1, 2015 (the "Effective Date"), is by and between AmBio Staffing, LLC, a Texas limited liability company, with offices located at 1565 North Central Expressway, Suite 300, Richardson, TX 75080 its successors and

Form Stocking Distribution Agreement, dated as of November 1, 2017, by and between CPM Medical Consultants, LLC and Maxim Surgical, LLC.

Exhibit 10.7 CPM MEDICAL CONSULTANTS, LLC STOCKING AND SUBDISTRIBUTION AGREEMENT THIS STOCKING AND SUBDISTRIBUTION AGREEMENT, dated as of [, 20] (the “Agreement”), is entered into by and between CPM Medical Consultants, LLC, a Texas Limited Liability Company having its principal place of business at 1565 N. Central Expressway, Suite 200, Richardson, TX 75080 (“Distributor”), and [], a [] corporati

Form Commission Agreement, dated as of November 1, 2017, by and between CPM Medical Consultants, LLC and Texas Overlord, LLC.

Exhibit 10.5 CPM MEDICAL CONSULTANTS, LLC SALES AND DISTRIBUTION SERVICES AGREEMENT THIS SALE AND DISTRIBUTION SERVICES AGREEMENT, dated as of March 1st, 2018 (the “Agreement”), is entered into by and between CPM MEDICAL CONSULTANTS, LLC, a Texas Limited Liability Company having its principal place of business at 1565 N. Central Expressway, Suite 200, Richardson, TX 75080 (“Distributor”), and ,a T

FZMD / Fuse Medical, Inc. NT 10-K

NT 10-K OMB APPROVAL OMB Number: 3235-0058 Expires: August 31, 2015 Estimated average burden hours per response 2.

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

Exhibit 99.1 CPM Medical Consultants, LLC Consolidated Financial Report December 31, 2017 Contents Report of Independent Registered Public Accounting Firm 1 Consolidated financial statements Consolidated balance sheets 2 Consolidated statements of operations 3 Consolidated statements of changes in member’s equity 4 Consolidated statements of cash flows 5 Notes to consolidated financial statements

Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 12, 2018 (December 29, 2017) FUSE MEDICAL, INC. (Exact name of Registrant as specified in its charter) Delaware 000-10093 59-1224913 (State or other jurisdiction of incorporat

FUSE MEDICAL, INC. AND CPM MEDICAL CONSULTANTS, LLC

Exhibit 99.2 FUSE MEDICAL, INC. UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL STATEMENTS On December 29, 2017, Fuse Medical, Inc. (the “Company”) completed the previously-announced acquisition of CPM Medical Consultants, LLC (“CPM”), a Texas limited liability company, pursuant to that certain Purchase Agreement, by and between the Company and NC 143 Family Holdings, LP, dated December 15, 2017,

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 23, 2018 (January 18, 2018) FUSE MEDICAL, INC. (Exact name of Registrant as specified in its charter) Delaware 000-10093 59-1224913 (State or other jurisdiction of i

Amendment Number 3 to the 2017 Equity Incentive Plan of Fuse Medical Inc. dated February 15, 2018 (filed as Exhibit 4.1 to the Company’s Form 8-K filed February 23, 2018 and incorporated herein by reference).

EX-4.1 EXHIBIT 4.1 2017 EQUITY INCENTIVE PLAN OF FUSE MEDICAL, INC. AMENDMENT NO. 3 February 15, 2018 Section 2.0. The Definition of “Plan” in the 2017 Equity Incentive Plan of Fuse Medical, Inc., dated April 5, 2017, is removed in its entirety and replaced by the following: 2.0 “Plan” means this 2017 Equity Incentive Plan, as amended and/or amended and restated from time to time. Section 4.1. Sec

Regulation FD Disclosure, Financial Statements and Exhibits

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 23, 2018 (February 15, 2018) FUSE MEDICAL, INC. (Exact name of Registrant as specified in its charter) Delaware 000-10093 59-1224913 (State or other jurisdiction of

Amended and Restated Business Loan Agreement, dated December 31, 2017, by and among ZB, N.A. (D/B/A Amegy Bank), Fuse Medical., and CPM Medical Consultants, LLC (filed as Exhibit 10.1 to our Company’s Form 8-K filed on January 11, 2018 and incorporated herein by reference).

EX-10.1 2 fzmd-ex1016.htm EX-10.1 Exhibit 10.1 AMENDED AND RESTATED BUSINESS LOAN AGREEMENT dated as of December 31, 2017 among ZB, N.A. (d/b/a AMEGY BANK), as Lender and FUSE MEDICAL, INC. and CPM MEDICAL CONSULTANTS, LLC, as Co-Borrowers Exhibit 10.1 Table of Contents Page ARTICLE I - DEFINITIONS 1 Section 1.1 Definitions1 Section 1.2 UCC Terms12 Section 1.3 Accounting Terms and Determinations12

FUSE MEDICAL, INC. Fuse Medical, Inc. Announces Engagement of Montgomery, Coscia, Greilich, LLP.

fzmd-ex99131.htm Exhibit 99.1 Contact: Fuse Medical, Inc. Attention: Devon Peddie, Investor Relations Analyst 1565 North Central Expressway, Suite 220 Richardson, Texas 75080 Office (469) 862-3030 Facsimile (469) 862-3035 [email protected] FUSE MEDICAL, INC. Fuse Medical, Inc. Announces Engagement of Montgomery, Coscia, Greilich, LLP. RICHARDSON, TX, January 11, 2018 /Businesswire/ - Fuse Medic

Letter from LaPorte dated January 11, 2018.

fzmd-ex1617.htm Exhibit 16.1 LaPorte CPAs & Business Advisors 5100 Village Walk, Suite 300 Covington, LA 70433 PHONE: 985.892.5850 FAX: 985.892.5956 LaPorte.com January 11, 2018 Office of the Chief Accountant Securities and Exchange Commission 450 Fifth Street, N.W. Washington, DC 20549 LaPorte was furnished with a copy of the disclosures included on Form 8-K for Fuse Medical, Inc. (Commission Fil

Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Other Events

fzmd-8k20180105.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 11, 2018 (January 5, 2018) FUSE MEDICAL, INC. (Exact name of Registrant as specified in its charter) Delaware 000-10093 59-1224913 (State or other jurisdic

FUSE MEDICAL, INC. AND CPM MEDICAL CONSULTANTS, LLC

fzmd-ex99171.htm EXHIBIT 99.1 FUSE MEDICAL, INC. UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL STATEMENTS On December 29, 2017, Fuse Medical, Inc. (the ?Company?) completed the previously-announced acquisition of CPM Medical Consultants, LLC (?CPM?), a Texas limited liability company, pursuant to that certain Purchase Agreement, by and between the Company and NC 143 Family Holdings, LP, dated D

FUSE MEDICAL, INC.

fzmd-ex9927.htm EXHIBIT 99.2 Contact: Fuse Medical, Inc. Attention: Devon Peddie, Investor Relations Analyst 1565 North Central Expressway, Suite 220 Richardson, Texas 75080 Office (469) 862-3030 Facsimile (469) 862-3035 [email protected] FUSE MEDICAL, INC. Fuse Medical, Inc. Completes Acquisition of CPM Medical Consultants, LLC RICHARDSON, TX, January 5, 2018 /Businesswire/ - Fuse Medical, Inc

FZMD / Fuse Medical, Inc. 8-K (Current Report)

fzmd-8k20171229.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 5, 2018 (December 29, 2017) FUSE MEDICAL, INC. (Exact name of Registrant as specified in its charter) Delaware 000-10093 59-1224913 (State or other jurisdi

FUSE MEDICAL, INC.

fzmd-ex9929.htm EXHIBIT 99.2 Contact: Fuse Medical, Inc. Attention: Devon Peddie, Investor Relations Analyst 1565 North Central Expressway, Suite 220 Richardson, Texas 75080 Office (469) 862-3030 Facsimile (469) 862-3035 [email protected] FUSE MEDICAL, INC. Fuse Medical, Inc. Signs Definitive Purchase Agreement to Acquire CPM Medical Consultants, LLC RICHARDSON, TX, December 19, 2017 /Businessw

Fairness Opinion Related to the Acquisition of CPM Medical Consultants, LLC by Fuse Medical, Inc. December 12, 2017 Prepared for: Board of Directors Fuse Medical, Inc.

fzmd-ex991146.htm EXHIBIT 99.1 Fairness Opinion Related to the Acquisition of CPM Medical Consultants, LLC by Fuse Medical, Inc. December 12, 2017 Prepared for: Board of Directors Fuse Medical, Inc. EXHIBIT 99.1 December 12, 2017 Board of Directors Fuse Medical, Inc. 1565 North Central Expressway Suite 220 Richardson, TX 75080 Dear Members of the Board: ValueScope, Inc. has been engaged to advise

FZMD / Fuse Medical, Inc. 8-K (Current Report)

fzmd-8k20171214.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 19, 2017 (December 14, 2017) FUSE MEDICAL, INC. (Exact name of Registrant as specified in its charter) Delaware 000-10093 59-1224913 (State or other juris

Purchase Agreement by and between Fuse Medical, Inc. and NC 143 Family Holdings, LP dated December 15, 2017 (filed as Exhibit 2.1 to the Company’s Form 8-K, filed on December 19, 2017 and incorporated herein by reference).

fzmd-ex21692.htm EXHIBIT 2.1 Execution Version PURCHASE AGREEMENT by and between NC 143 FAMILY HOLDINGS, LP and FUSE MEDICAL, INC. dated December 15, 2017 EXHIBIT 2.1 Table of Contents Page ARTICLE I Definitions 1 ARTICLE II Purchase and sale 11 Section 2.01 Purchase and Sale11 Section 2.02 Purchase Price11 Section 2.03 Transactions to be Effected at the Closing.12 Section 2.04 Purchase Price Adju

Letter from Weinberg dated November 21, 2017.

fzmd-ex1617.htm EXHIBIT 16.1 Weinberg & Company, P.A. Certified Public Accountants November 21, 2017 Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549-7561 Dear Sirs/Madams: We have read Item 4.01(a) of Fuse Medical Inc.?s Form 8-K dated November 21, 2017, and we agree with the statements made therein. We have no basis on which to agree or disagree with the statements ma

Financial Statements and Exhibits

fzmd-8k20171116.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 21, 2017 (November 16, 2017) FUSE MEDICAL, INC. (Exact name of Registrant as specified in its charter) Delaware 000-10093 59-1224913 (State or other juris

Regulation FD Disclosure, Financial Statements and Exhibits

fzmd-8k20171109.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 9, 2017 FUSE MEDICAL, INC. (Exact name of Registrant as specified in its charter) Delaware 000-10093 59-1224913 (State or other jurisdiction of incorporat

FUSE MEDICAL, INC.

fzmd-ex9916.htm EXHIBIT 99.1 Contact: Fuse Medical, Inc. 1565 North Central Expressway, Suite 220 Richardson, Texas 75080 Office (469) 862-3030 Facsimile (469) 862-3035 [email protected] FUSE MEDICAL, INC. Fuse Medical, Inc. Signs Non-Binding Letter of Intent to Purchase all of the Outstanding Membership Units of CPM Medical Consultants, LLC Richardson, Texas ? November 9th, 2017 ? Fuse Medical

FZMD / Fuse Medical, Inc. 10-Q (Quarterly Report)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: September 30, 2017 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 000-10093 Fuse Medical, Inc. (Exact name of registrant as spec

Amendment Number 1 to the 2017 Equity Incentive Plan of Fuse Medical, Inc. dated September 21, 2017 (filed as Exhibit 4.1 to the Company’s Form 8-K/A filed November 6, 2017 and incorporated herein by reference.)

fzmd-ex416.htm EXHIBIT 4.1 2017 EQUITY INCENTIVE PLAN OF FUSE MEDICAL, INC. AMENDMENT NO. 1 September 21, 2017 Section 4.1 of the 2017 Equity Incentive Plan of Fuse Medical, Inc., dated April 5, 2017, is removed in its entirety and replaced by the following: 4.1Subject to adjustment in accordance with Section 11, a total of 2,500,000 shares of Common Stock shall be available for the grant of Award

Amendment Number 2 to the 2017 Equity Incentive Plan of Fuse Medical, Inc. dated October 4, 2017 (filed as Exhibit 4.2 to the Company’s Form 8-K/A filed November 6, 2017 and incorporated herein by reference.)

fzmd-ex427.htm EXHIBIT 4.2 2017 EQUITY INCENTIVE PLAN OF FUSE MEDICAL, INC. AMENDMENT NO. 2 October 4, 2017 Section 4.1 of the 2017 Equity Incentive Plan of Fuse Medical, Inc., dated April 5, 2017, is removed in its entirety and replaced by the following: 4.1Subject to adjustment in accordance with Section 11, a total of 4,500,000 shares of Common Stock shall be available for the grant of Awards u

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Entry into a Material Definitive Agreement, Financial Statements and Exhibits

fzmd-8ka20170921.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 6, 2017 (September 21, 2017) FUSE MEDICAL, INC. (Exact name of Registrant as specified in its charter) Delaware 000-10093 59-1224913 (State or other ju

Fuse Medical S-8

S-8 1 fzmd-s8.htm S-8 As filed with the Securities and Exchange Commission on October 11, 2017 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 FUSE MEDICAL, INC. (Exact name of Registrant as specified in its charter) Delaware 59-1224913 (State or other jurisdiction of incorporation or org

Form of Restricted Stock Award for Special Board Compensation of Fuse Medical, Inc. (filed as Exhibit 10.2 to the Company’s Form 8-K filed October 10, 2017, and incorporated herein by reference).

EX-10.2 3 fzmd-ex10251.htm EX-10.2 EXHIBIT 10.2 FUSE MEDICAL, INC. 2017 EQUITY INCENTIVE PLAN RESTRICTED STOCK AWARD NOTICE Fuse Medical, Inc. (the “Company”) hereby grants to you a Restricted Stock Award (the “Award”) for shares of the Company's Common Stock under the Company's 2017 Equity Incentive Plan (the “Plan”). The Award is subject to all the terms and conditions set forth in this Restrict

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities

fzmd-8k20171010.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 10, 2017 FUSE MEDICAL, INC. (Exact name of Registrant as specified in its charter) Delaware 000-10093 59-1224913 (State or other jurisdiction of incorporat

Form of Restricted Stock Award for Board Compensation of Fuse Medical, Inc. (filed as Exhibit 10.1 to the Company’s Form 8-K filed October 10, 2017, and incorporated herein by reference).

fzmd-ex10150.htm EXHIBIT 10.1 FUSE MEDICAL, INC. 2017 EQUITY INCENTIVE PLAN RESTRICTED STOCK AWARD NOTICE Fuse Medical, Inc. (the “Company”) hereby grants to you a Restricted Stock Award (the “Award”) for shares of the Company's Common Stock under the Company's 2017 Equity Incentive Plan (the “Plan”). The Award is subject to all the terms and conditions set forth in this Restricted Stock Award Not

FZMD / Fuse Medical, Inc. 10-Q (Quarterly Report)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: June 30, 2017 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 000-10093 Fuse Medical, Inc. (Exact name of registrant as specified

Fuse Medical 8-K (Current Report/Significant Event)

fzmd-8k20170801.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 3, 2017 (August 1, 2017) FUSE MEDICAL, INC. (Exact name of Registrant as specified in its charter) Delaware 000-10093 59-1224913 (State or other jurisdictio

Assignment of Sublease and Consent, dated July 17, 2017, by and between (i) PBIII-SOP, LP, (ii) PHILLIP GALYEN, PC, d/b/a Bailey & Galyen, (iii) Fuse Medical, Inc., and (iv) LawConnect, Inc. d/b/a GetLegal.com (filed as Exhibit 10.2 to the Company’s Form 8-K, filed on July 19, 2017, and incorporated herein by reference).

fzmd-ex10243.htm EX ? 10.2 ASSIGNMENT OF SUBLEASE AND CONSENT THIS ASSIGNMENT OF SUBLEASE AND CONSENT (this ?Assignment?) is made and entered into July , 2017 (?Effective Date?), by and between (i) PBIII-SOP, LP, a Texas limited partnership (as successor in interest to the ownership of the Building, as defined herein) (?Landlord?); (ii) PHILLIP GALYEN, PC, d/b/a Bailey & Galyen (?Tenant?); (iii) F

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Financial Statements and Exhibits

fzmd-8k20170713.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 19, 2017 (July 13, 2017) FUSE MEDICAL, INC. (Exact name of Registrant as specified in its charter) Delaware 000-10093 59-1224913 (State or other jurisdiction

Commercial Property Lease Agreement dated July 19, 2017 by and between Fuse Medical, Inc. and 1565 North Central Expressway, LP (filed as Exhibit 10.1 to the Company’s Form 8-K, filed on July 19, 2017, and incorporated herein by reference).

fzmd-ex10144.htm EX ? 10.1 Commercial Property Lease Agreement This Commercial Property Lease Agreement ("Lease") is made and effective July 14, 2017, by and between 1565 North Central Expressway, LP ("Landlord") and Fuse Medical, Inc. ("Tenant"). Landlord is the Owner of land and improvements commonly known and numbered as 1565 North Central Expressway, Suite 220, Richardson, TX 75080. Landlord d

Sublease Agreement dated September 1, 2015, by and between Fuse Medical, Inc. and PHILLIP GALYEN, PC, d/b/a Bailey & Galyen (filed as Exhibit 10.3 to the Company’s Form 8-K, filed on July 19, 2017, and incorporated herein by reference).

fzmd-ex10391.htm EX – 10.3 EXHIBIT "A" to Consent SUBLEASE AGREEMENT This Sublease Agreement (the "Sublease") is made and entered into by and between PHILLIP GALYEN, P.C. d/b/a BAILEY & GALYEN (the "Sublessor") and Fuse Medical, Inc., a Delaware corporation (the "Sublessee"), effective as of the date of the last signature below (the "Effective Date"). In consideration of the mutual covenants and a